◈

Mechanistic Hypotheses

1

Failed cytotoxic clearance sustains the infiltrate

failed_cytotoxic_clearance EMERGING

Evidence balance 1 support

That in at least a subgroup, CLIPPERS is driven by an inability of cytotoxic lymphocytes to kill. Biallelic PRF1 or UNC13D lesions leave an antigen-bearing target uncleared, so the T cell response against it never resolves and becomes the chronic perivascular infiltrate that defines the disease. The attraction of this model is that it explains the chronicity - a feature the "immune-mediated inflammation" account merely restates - and it predicts the steroid dependence, since suppression removes the response without removing its stimulus. It is EMERGING rather than established: the association rests on 4 of 12 tested patients in one cohort plus two further UNC13D patients, no step between the degranulation defect and the brainstem lesion has been traced, and three of the four mutated patients subsequently showed features atypical for CLIPPERS.

Pathograph links

Impaired Cytotoxic Lymphocyte Granule-Mediated Killing -> Perivascular T-Lymphocytic Infiltration of Brainstem White Matter INDIRECT UNKNOWN INTERMEDIATES Proposed rather than demonstrated: failed cytotoxic clearance of an antigen-bearing target is suggested to sustain the T cell infiltrate. No study has traced the steps between the degranulation defect and the brainstem lesion.

Show evidence (1 reference)

PMID:33658321 SUPPORT Human Clinical

"In our patients presenting with adult-onset CLIPPERS, one-third have HLH gene mutations. This genetic treatable condition should be searched in patients with CLIPPERS, especially in those presenting with atypical findings."

States the frequency the hypothesis rests on and the authors' own clinical reading of it, including the qualifier that the association is strongest in atypical cases.

?

Discussions and Knowledge Gaps

3

Is the perivascular infiltrate in CLIPPERS T-cell dominant, as the founding and criteria-defining cohorts report, or can it be B-cell dominant?

KNOWLEDGE GAP clippers_infiltrate_lineage_contested

Attached to

pathophysiology#Perivascular T-Lymphocytic Infiltration of Brainstem White Matter

The disease's histopathological signature, and the name of the node it occupies in this entry, is a perivascular CD3-positive T-lymphocytic infiltrate. A six-patient series from mainland China reports the opposite in most of its biopsies: of four patients with an infiltrate, one was CD3-dominant and three were CD20-dominant, and the authors state the generalisation rather than leaving it as a local observation. Both readings cannot be the disease's typical histology, and the difference is not cosmetic. A B-cell-dominant infiltrate would sit differently against the entity-versus-syndrome question recorded separately in this entry, since the lymphomas that have declared themselves in CLIPPERS patients have been B-cell lymphomas. It would also change which maintenance agent the mechanism argues for. This entry keeps the T-cell node because the larger and criteria-defining cohorts support it and because the downstream pathograph - barrier breakdown, tissue injury, brainstem dysfunction - is unaffected either way, but it does not present the lineage as settled. Resolving it needs a re-read of archived biopsies under one staining protocol rather than another case series.

Show evidence (3 references)

PMID:33498046 SUPPORT Human Clinical

"among whom only 1 patient was dominated by CD3+ T cell infiltration and the other 3 patients were dominated by CD20+ B cell infiltration"

Gives the split this discussion is about, with the denominator, in one sentence.

PMID:20639547 REFUTE Human Clinical

"Neuropathology of biopsy material from four patients demonstrated white matter perivascular, predominantly T lymphocytic, infiltrate without granulomas, infection, lymphoma or vasculitis."

The founding cohort's opposite finding, graded REFUTE against the B-cell-dominant claim rather than against the disease description, so that the disagreement is legible from either side.

PMID:22777259 REFUTE Human Clinical

"Among 7 available brain biopsy specimens, staining was positive for perivascular CD4 T lymphocytes in 5 samples."

An independent nationwide series finding T-cell staining in most biopsies, which is why the T-cell reading is retained as the majority one.

What recruits the perivascular T-cell infiltrate in CLIPPERS, and against what antigen?

KNOWLEDGE GAP clippers_upstream_trigger_unknown

Attached to

pathophysiology#Perivascular T-Lymphocytic Infiltration of Brainstem White Matter

The pathograph in this entry begins at a tissue-level observation because nothing upstream of it has been established. No antigen, autoantibody, infectious trigger or susceptibility locus is known, and no diagnostic biomarker exists. The inference that the process is immune-mediated rests on two indirect arguments - the T-cell predominance of the infiltrate and the corticosteroid responsiveness - rather than on an identified immune target. Supplying a plausible upstream node here would misrepresent the state of the evidence, so the gap is recorded instead. It is also the gap that matters practically: a biomarker derived from the trigger is what would resolve the mimic problem recorded in the sibling discussion.

Is CLIPPERS a single disease entity, or a syndrome that collects several overlapping diseases and the prodromal phases of some of them - CNS lymphoma in particular?

KNOWLEDGE GAP clippers_entity_versus_syndrome

Attached to

disease#Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive To Steroids

This question was raised in print by the authors of the first fatal case and has not been settled. Patients meeting the full clinical, radiological and histopathological definition have gone on to biopsy-confirmed lymphomatoid granulomatosis and fatal CNS B-cell lymphoma, in one case after seven months of reliable steroid response. The 2017 criteria sharpened the boundary but were derived from a cohort with a median follow-up of 44 months, and the concern is specifically about what declares itself later than that. The entity question bears directly on how this entry should be read: if CLIPPERS is partly a prodrome, then the pathograph above describes a common final inflammatory pattern rather than a disease mechanism.

Show evidence (4 references)

PMID:23649857 SUPPORT Human Clinical

"Therefore, the question remains whether CLIPPERS is an actual new disease entity or represents a syndrome that includes different overlapping diseases and their prestages."

States the open question in the authors' own words, which is what this discussion records rather than resolves.

PMID:23649857 SUPPORT Human Clinical

"During follow-up, however, treatment failed, and he had a biopsy-confirmed diagnosis of lymphomatoid granulomatosis that evolved into fatal B-cell lymphoma of the central nervous system."

Documents the specific course that motivates the question: a fully characterised CLIPPERS presentation that later proved to be an evolving lymphoma.

PMID:36029706 SUPPORT Human Clinical

"Sixteen percent of the cases were associated with malignancy, mostly hematologic malignancies."

Moves the question from anecdote to a rate: one in six published cases carries a malignancy association, which is the scale of the problem the entity question is about.

+ 1 more reference

⚙

Pathophysiology

5

Impaired Cytotoxic Lymphocyte Granule-Mediated Killing

Mechanism confidence: Hypothetical

Present in a genetic subgroup rather than in every patient. Roughly a third of adult CLIPPERS patients tested carry biallelic mutations in primary HLH genes - PRF1, whose product perforin punctures the target-cell membrane, or UNC13D, whose product Munc13-4 is required one step earlier for cytotoxic granule fusion. Both lesions converge on the same failure: cytotoxic lymphocytes cannot kill. The proposed consequence is that antigen-bearing target cells are not cleared, so the T cell response against them persists instead of resolving - which would make the chronic perivascular infiltrate a consequence of failed killing rather than of excessive activation. Two things keep this node hypothetical rather than established. None of the mutated patients met systemic HLH criteria, so this is not simply HLH presenting in the brain. And three of the four went on to show findings atypical for CLIPPERS, one developing systemic non-Hodgkin lymphoma - which leaves open whether they had CLIPPERS at all.

Failed cytotoxic clearance sustains the infiltrate

natural killer cell CL:0000623 cytotoxic T cell CL:0000910

PRF1 hgnc:9360 UNC13D hgnc:23147

natural killer cell mediated cytotoxicity GO:0042267 ↓ DECREASED regulated exocytosis of cytotoxic granules GO:0045055 ↓ DECREASED

Downstream

Perivascular T-Lymphocytic Infiltration of Brainstem White Matter Proposed rather than demonstrated: failed cytotoxic clearance of an antigen-bearing target is suggested to sustain the T cell infiltrate. No study has traced the steps between the degranulation defect and the brainstem lesion.

Show evidence (2 references)

PMID:33658321 SUPPORT Human Clinical

"Mutations involved in HLH were identified in 2 definite and 2 probable CLIPPERS (4/12)."

Quantifies how often this node applies: a third of the tested adult patients, not all of them.

PMID:33658321 SUPPORT Human Clinical

"None of the mutated patients reached the criteria for systemic HLH."

Establishes that this is not systemic HLH with brain involvement, which is what makes the node a distinct proposal rather than a reclassification.

Perivascular T-Lymphocytic Infiltration of Brainstem White Matter

The earliest event anyone has observed. Biopsy of affected brainstem white matter shows a dense perivascular infiltrate dominated by CD3-positive T lymphocytes, with mild B-lymphocyte and moderate macrophage components, present in meninges and in both white and grey matter. Granulomas, organisms, lymphoma and vasculitis are absent, which is what distinguishes the finding rather than what explains it. What recruits these cells, and against what, is unknown - see the knowledge gap attached to this node. The T-cell predominance in this node's name is the finding of the founding and criteria-defining cohorts, and it is contested: a six-patient Chinese series found the infiltrate dominated by CD20-positive B cells in three of the four biopsies that showed an infiltrate at all. The node keeps its name because the larger cohorts support it, but the lineage should be read as the majority finding rather than a settled one. The contradiction is recorded as a REFUTE item below and in the clippers_infiltrate_lineage_contested discussion.

CD3-positive T lymphocyte CL:0000084 B lymphocyte CL:0000236 macrophage CL:0000235

T cell migration into brainstem white matter GO:0072678 ↑ INCREASED

brainstem white matter UBERON:0014891

Downstream

Blood-Brain Barrier Breakdown at Pontine Perforating Vessels The perivascular location of the infiltrate is what makes the enhancement pattern perivascular: inflammation sits on the small perforating vessels of the pons.

Inflammatory Tissue Injury with Astrogliosis and Secondary Myelin Loss

Show evidence (3 references)

PMID:33498046 REFUTE Human Clinical

"the other 3 patients were dominated by CD20+ B cell infiltration"

Contradicts the T-cell predominance this node is named for. Three of the four informative biopsies in this series were B-cell dominant, so the lineage claim is not settled; graded REFUTE against this node rather than quietly folded into it.

PMID:33498046 REFUTE Human Clinical

"the lymphocytic infiltration in the lesions of CLIPPERS may be dominated by CD20+ B cells instead of CD3+ T cells"

The authors' own statement of the conclusion, which is what makes this a claim about the disease rather than an incidental observation in one series.

PMID:29050399 SUPPORT Human Clinical

"Brain neuropathology on 14 CLIPPERS cases demonstrated marked CD3-positive T-lymphocyte, mild B-lymphocyte and moderate macrophage infiltrates"

Gives the cellular composition of the infiltrate, in the largest biopsied series, and the relative weighting of the three populations bound on this node.

Blood-Brain Barrier Breakdown at Pontine Perforating Vessels

Inflammation of the small perforating vessels makes them leak gadolinium, producing the radiological signature of the disease: symmetric, curvilinear and punctate enhancement peppering the pons. The 2017 criteria sharpened this into discriminating features - homogeneous enhancing nodules under 3 mm without ring enhancement or mass effect, and T2 signal abnormality not significantly exceeding the T1 enhancement. Those two negatives are what separate the pattern from lymphoma and from demyelinating disease.

pons UBERON:0000988

Downstream

Pontine perivascular gadolinium enhancement

Show evidence (1 reference)

PMID:29050399 SUPPORT Human Clinical

"CLIPPERS patients had brainstem predominant perivascular gadolinium enhancing lesions on magnetic resonance imaging that were discriminated from non-CLIPPERS by: homogenous gadolinium enhancing nodules <3 mm in diameter without ring-enhancement or mass effect, and homogenous T2 signal..."

Gives the enhancement characteristics produced by this node, including the two negative features that carry the discriminating power.

Inflammatory Tissue Injury with Astrogliosis and Secondary Myelin Loss

Sustained infiltration produces variable tissue destruction, reactive astrogliosis and secondary myelin loss. The myelin loss is explicitly secondary - this is not a primary demyelinating disease - which matters for both classification and for reading the MRI.

astrocyte CL:0000127

reactive gliosis GO:0150103 ↑ INCREASED

Downstream

Brainstem and Cerebellar Dysfunction

Show evidence (1 reference)

PMID:29050399 SUPPORT Human Clinical

"associated with variable tissue destruction, astrogliosis and secondary myelin loss"

Names the three components of tissue injury this node asserts, and marks the myelin loss as secondary.

Brainstem and Cerebellar Dysfunction

Injury in the pons, middle cerebellar peduncles and cerebellum produces the clinical syndrome: diplopia from ocular motor involvement, facial paraesthesia from trigeminal tract involvement, and gait ataxia from cerebellar and peduncular involvement, with myelopathic signs when the cord is affected.

brainstem UBERON:0002298

Downstream

Diplopia

Dysarthria

Facial paraesthesia

Gait ataxia

Myelopathy

Cognitive impairment

Show evidence (1 reference)

PMID:20639547 SUPPORT Human Clinical

"All eight patients (five female, three male) presented with episodic diplopia or facial paresthesias with subsequent brainstem and occasionally myelopathic symptoms"

Maps the anatomical site of injury onto the presenting clinical syndrome this node produces.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

7

Eye 1

Diplopia FREQUENT HP:0000651

The band is qualitative. No published series reports a percentage for diplopia in CLIPPERS; FREQUENT rests on two cohorts describing it as a typical or frequent feature.

Show evidence (2 references)

PMID:20639547 SUPPORT Human Clinical

"All eight patients (five female, three male) presented with episodic diplopia or facial paresthesias"

Documents diplopia as a presenting feature across the founding cohort.

PMID:22777259 SUPPORT Human Clinical

"manifested frequent cerebellar ataxia and diplopia"

An independent nationwide series calling diplopia frequent across 42 relapses, which is the anchor for the FREQUENT band rather than the presenting-feature sentence above.

Nervous System 6

Facial paraesthesia FREQUENT Paresthesia HP:0003401

The band is qualitative, from one six-patient series describing the feature as common. No series reports a percentage.

Show evidence (2 references)

PMID:29050399 SUPPORT Human Clinical

"Clinical symptoms of gait ataxia, diplopia, cognitive impairment, and facial paraesthesia did not discriminate CLIPPERS from non-CLIPPERS."

Documents facial paraesthesia as a feature of the syndrome while recording explicitly that it carries no discriminating value, which is the more useful fact. It says nothing about frequency, which is why the band needs the item below.

PMID:33498046 SUPPORT Human Clinical

"The common clinical manifestations included ataxia, dysarthria, diplopia, dysphagia, dizziness, cognitive impairment, facial paresthesia, and paralysis."

Names facial paraesthesia among the common manifestations, which is the frequency anchor for the band. A six-patient series, so it supports a qualitative band and not a rate.

Gait ataxia FREQUENT HP:0002066

Ataxia is the most common presenting symptom across the 140 published cases, but no source gives a rate, so the band is FREQUENT on a qualitative ranking rather than on a proportion.

Show evidence (2 references)

PMID:29050399 SUPPORT Human Clinical

"Clinical symptoms of gait ataxia, diplopia, cognitive impairment, and facial paraesthesia did not discriminate CLIPPERS from non-CLIPPERS."

Records gait ataxia among the syndrome's clinical features, and its lack of discriminating value. It carries no frequency information, which the item below supplies.

PMID:36029706 SUPPORT Human Clinical

"Ataxia was the most common presenting symptom."

The frequency anchor for this band, from the 140-patient systematic review. It ranks ataxia first among presenting symptoms without giving a percentage, which is why the band stays qualitative.

Dysarthria FREQUENT HP:0001260

Bound to HP:0001260 Dysarthria rather than to a cerebellar-specific term. The cerebellar qualifier is carried in preferred_term because the sources describe cerebellar dysarthria specifically, while the HPO term for the sign itself is unqualified.

Show evidence (2 references)

PMID:36029706 SUPPORT REVIEW SYNTHESIS Human Clinical

"characterized by symptoms referable to the brainstem and cerebellum such as, diplopia, gait ataxia and cerebellar dysarthria"

Names cerebellar dysarthria as one of the three defining symptoms of the syndrome. quote_role REVIEW_SYNTHESIS because the citing publication is a systematic review and this sentence is its characterisation of a clinical picture drawn from the cases it pooled, rather than a measurement it made.

PMID:33498046 SUPPORT Human Clinical

"The common clinical manifestations included ataxia, dysarthria, diplopia, dysphagia, dizziness, cognitive impairment, facial paresthesia, and paralysis."

An independent series listing dysarthria among the common manifestations, which is the frequency anchor for the band.

Cognitive impairment OCCASIONAL HP:0100543

Left at OCCASIONAL rather than raised. The one source describing cognitive impairment as a common manifestation is a six-patient series; the larger cohorts list it among the features evaluated without stating how often it occurred, and the 140-patient systematic review ranks only ataxia. Raising the band on six patients would assert more than the literature supports.

Show evidence (2 references)

PMID:29050399 SUPPORT Human Clinical

"Clinical symptoms of gait ataxia, diplopia, cognitive impairment, and facial paraesthesia did not discriminate CLIPPERS from non-CLIPPERS."

Records cognitive impairment among the evaluated clinical features of the syndrome. It says nothing about how often it occurs.

PMID:33498046 SUPPORT Human Clinical

"The common clinical manifestations included ataxia, dysarthria, diplopia, dysphagia, dizziness, cognitive impairment, facial paresthesia, and paralysis."

The only source that calls cognitive impairment common. Recorded, but not treated as sufficient to raise the band - see notes.

Myelopathy OCCASIONAL HP:0002196

Show evidence (1 reference)

PMID:20639547 SUPPORT Human Clinical

"with subsequent brainstem and occasionally myelopathic symptoms"

Documents myelopathic involvement as an occasional and subsequent rather than presenting feature.

Pontine perivascular gadolinium enhancement VERY_FREQUENT Abnormal brainstem MRI signal intensity HP:0012747

Show evidence (1 reference)

PMID:20639547 SUPPORT Human Clinical

"All patients had symmetric curvilinear gadolinium enhancement peppering the pons and extending variably into the medulla, brachium pontis, cerebellum, midbrain and occasionally spinal cord."

Documents the enhancement pattern and its anatomical distribution in every patient of the founding cohort.

🧬

Genetic Associations

2

PRF1

Gene: PRF1 hgnc:9360 relationship_type: SUSCEPTIBILITY

Show evidence (1 reference)

PMID:33658321 SUPPORT Human Clinical

"Three of them had biallelic PRF1 mutations with reduced perforin expression in natural killer cells."

Documents biallelic PRF1 mutations with a demonstrated protein-level consequence in adult CLIPPERS patients.

UNC13D

Gene: UNC13D hgnc:23147 relationship_type: SUSCEPTIBILITY

Show evidence (2 references)

PMID:33658321 SUPPORT Human Clinical

"The remaining patient had biallelic UNC13D mutations with cytotoxic lymphocyte impaired degranulation."

Documents biallelic UNC13D mutations with a functional degranulation defect in an adult CLIPPERS patient.

PMID:41781714 SUPPORT Human Clinical

"We report two patients with CLIPPERS-like brain MRI findings who carried the same missense UNC13D variant in one allele along with deleterious variants in the opposite allele."

Independently replicates the UNC13D association in two further patients, which is what moves it beyond a single-cohort observation.

💊

Medical Actions

3

High-Dose Glucocorticosteroid Therapy

Action: Pharmacotherapy NCIT:C15986

Agent: glucocorticoid CHEBI:24261

Platform: Small molecule

High-dose corticosteroids produce a marked clinical and radiological response, and in the 2017 series this was universal - 23 of 23 confirmed patients. It is not by itself a diagnostic test: 8 of 12 patients who turned out to have another disease also improved clinically on steroids, and the discriminating feature was radiological response, seen in only 2 of those 12.

Mechanism Target:

Perivascular T-Lymphocytic Infiltration of Brainstem White Matter — Corticosteroids suppress the T-cell infiltrate directly; the radiological and clinical improvement follows from that.

Show evidence (2 references)

PMID:29050399 SUPPORT Human Clinical

"Marked clinical and radiological corticosteroid responsiveness was observed in CLIPPERS (23/23)"

Establishes universal corticosteroid responsiveness in the confirmed cohort.

PMID:29050399 SUPPORT Human Clinical

"Corticosteroid responsiveness was common but not universal in non-CLIPPERS [clinical improvement (8/12); radiological improvement (2/12); clinical worsening on discontinuation (3/8)]."

Records that steroid response occurs in the mimics too, which is why responsiveness cannot stand as a diagnostic criterion on its own despite being in the disease name.

Chronic Steroid-Sparing Immunosuppression

Action: Immunosuppressive Therapy NCIT:C15261

Agent: methotrexate CHEBI:44185

Platform: Small molecule

Because relapse on taper is universal, patients require indefinite maintenance therapy, with steroid-sparing agents such as methotrexate used to limit cumulative corticosteroid toxicity. The evidence base is case series and case reports; there is no controlled trial and no agreed regimen.

Mechanism Target:

Perivascular T-Lymphocytic Infiltration of Brainstem White Matter — Maintenance immunosuppression holds the same infiltrate suppressed once corticosteroids are withdrawn.

Show evidence (3 references)

PMID:20639547 SUPPORT Human Clinical

"Patients routinely worsened following glucocorticosteroid taper and required chronic glucocorticosteroid or other immunosuppressive therapy."

Establishes the need for chronic immunosuppression as a consequence of universal taper-dependent relapse.

PMID:36029706 SUPPORT Human Clinical

"The overall relapse rate was 59.2%, and the duration of steroid therapy was considerably shorter in the relapsed cases than in the non-relapsed (mean 6.19±7.9 vs. 10.14±12.1 days, respectively, P = 0.04)"

The only quantitative handle on how to give the treatment: relapse tracked with a shorter acute course, not with the dose. Note the comparison is observational across pooled case reports, so it cannot separate a short course causing relapse from a milder illness being treated briefly.

PMID:36029706 SUPPORT Human Clinical

"we recommend that CLIPPERS be treated with high-dose steroid therapy for at least ten days during the acute phase with a very slow taper"

The recommendation the authors draw from that comparison.

Intravenous Immunoglobulin

Action: Intravenous Immunoglobulin Therapy NCIT:C121331

Agent: human immunoglobulin G NCIT:C80829

Platform: Other

Tried for a relapse in one reported patient and did not work: no clinical improvement, while the same patient recovered promptly after each course of intravenous methylprednisolone. Recorded because a documented failure is what tells a clinician not to spend a relapse on it, and because the contrast with the steroid response in the same patient is the informative part. One patient, so this constrains the expected effect rather than excluding it.

Mechanism Target:

Perivascular T-Lymphocytic Infiltration of Brainstem White Matter — The intended target is the same infiltrate the corticosteroids suppress. The link is recorded with REFUTE evidence because the intervention was given and the infiltrate's clinical consequences did not remit.

Show evidence (1 reference)

PMID:36938308 REFUTE Human Clinical

"Intravenous immunoglobulins (IVIg) were administered for recurrence, with no clinical improvement."

The treatment reached the patient and the relapse did not respond, which is what makes this a refutation of the link rather than an absence of evidence about it.

Show evidence (1 reference)

PMID:36938308 REFUTE Human Clinical

"IVIg had a poor effect on the acute phase of CLIPPERS symptoms. Compared with other immunosuppressants, IVIg is less effective in suppressing the relapse of CLIPPERS."

The authors' own conclusion, stated as a comparison against the immunosuppressants that do work, which is the clinically useful form of the finding.

🌍

Environmental Factors

1

Intracranial Epstein-Barr virus infection

EBV has been reported within the CNS of a CLIPPERS patient, and EBV-driven B-cell lymphoma has emerged during paediatric CLIPPERS. Whether EBV is a trigger, a passenger reactivating under immunosuppression, or a marker of the lymphoproliferative process that some CLIPPERS turns out to be, is unresolved - the reported case had been in remission from Hodgkin lymphoma for eleven years before presenting. Recorded as MODULATES rather than TRIGGERS for that reason.

Show evidence (1 reference)

PMID:27861371 SUPPORT Human Clinical

"The pathophysiology of CLIPPERS still remains unclear and the reports are quite few."

Records the state of mechanistic knowledge against which this association has to be read: an unexplained disease, so an association is not yet a mechanism.

Mechanism Target:

MODULATES Perivascular T-Lymphocytic Infiltration of Brainstem White Matter — Association only. No study has shown that EBV initiates or sustains the infiltrate.

Show evidence (1 reference)

PMID:27861371 SUPPORT INDIRECT Human Clinical

"we report a case of CLIPPERS presenting with intracranial Epstein-Barr virus (EBV) infection and diffuse white matter involvement"

Documents the co-occurrence of intracranial EBV with CLIPPERS. Graded INDIRECT because a single case of co-occurrence does not establish that the virus acts on the mechanism.

🔬

Diagnosis

4

Contrast-enhanced brain MRI with size and T2 constraints

MRI is the discriminating test, but only when read against the 2017 criteria rather than for the enhancement pattern alone: enhancing nodules must be under 3 mm, without ring enhancement or mass effect, and the T2 abnormality must not significantly exceed the T1 enhancement. Those constraints exist because the gross pattern alone had been letting other diseases in.

Show evidence (1 reference)

PMID:29050399 SUPPORT Human Clinical

"the lack of formalized diagnostic criteria has led to reports of patients with dissimilar features purported to have CLIPPERS"

States the problem the quantitative imaging constraints were written to solve, which is why the constraints rather than the pattern are the diagnostic content.

Brain biopsy

Biopsy shows the perivascular CD3-positive T-cell infiltrate and, critically, excludes lymphoma, granulomatous disease, infection and vasculitis. Because no biomarker exists and because CNS lymphoma has repeatedly declared itself late in patients who initially met every CLIPPERS criterion, there is a published argument for biopsying early rather than after steroid failure.

Show evidence (2 references)

PMID:35126669 SUPPORT Human Clinical

"Hence, we propose that in the absence of other diagnostic markers, brain biopsy should be performed as early as possible in CLIPPERS patients."

States the case for early biopsy and its premise - the absence of any diagnostic marker - which is the reason this test carries the diagnostic weight it does.

PMID:35126669 SUPPORT Human Clinical

"Yet diagnostic biomarkers are missing and other immune-mediated, (para-) infectious and malignant causes mimic CLIPPERS-like MRI presentations."

Records that no biomarker exists and that the MRI appearance is mimicked by several disease classes, which is what leaves biopsy as the discriminating test.

Cerebrospinal fluid examination

CSF is examined to exclude infection and to characterise the inflammation, not to confirm the diagnosis: the findings are mild and inconstant. Oligoclonal bands appear in a minority, and the lymphocyte population shows the raised CD4:CD8 ratio consistent with the CD4-predominant perivascular infiltrate seen on biopsy. A normal CSF does not argue against CLIPPERS.

Show evidence (1 reference)

PMID:22777259 SUPPORT Human Clinical

"Inconstant oligoclonal bands were found on cerebrospinal fluid investigation in 4 patients, with an increased T-cell ratio of CD4 to CD8."

Gives both findings and, in the word inconstant, the reason this test cannot confirm or exclude the diagnosis.

Screening for occult malignancy

Not a test for CLIPPERS but a test that must accompany it. Sixteen percent of published cases carry an associated malignancy, mostly haematological, and mortality in that group is three times the overall figure. The systematic review makes the recommendation explicitly, and it is the practical consequence of the entity-versus-syndrome question recorded in this entry's discussions.

Show evidence (2 references)

PMID:36029706 SUPPORT Human Clinical

"These patients should be screened for associated malignancies, especially hematological malignancies."

The recommendation itself, from the largest pooled series.

PMID:36029706 SUPPORT Human Clinical

"The overall mortality rate was 10%, but mortality in patients with malignancy was 30% and it was 12% in patients with relapses."

Quantifies why the screening matters: an associated malignancy triples mortality.

📈

Progression

2

Relapse

Duration: mean 2.5 months

Relapses are discrete and self-limited in duration but not in consequence: the mean Expanded Disability Status Scale score during a relapse in the French nationwide series was 4, and the residual score after pulse corticosteroid treatment was 1.9. The gap between those two numbers is what maintenance therapy is for.

Show evidence (1 reference)

PMID:22777259 SUPPORT Human Clinical

"Relapses lasted a mean duration of 2.5 months, manifested frequent cerebellar ataxia and diplopia, and were associated with a mean Expanded Disability Status Scale (EDSS) score of 4"

Gives the duration and the disability level of a relapse, which is what this phase records.

Long-term course

Relapsing-remitting, with no progressive phase described. Disability therefore accrues stepwise from the severity of individual relapses rather than accumulating between them, and the patients who ended with a high residual score are the ones who had had severe relapses and who show brainstem and spinal cord atrophy on imaging. This is the structural reason the entry treats delayed or withheld treatment as the thing that determines outcome: the one untreated patient in the series reached a score of 10.

Show evidence (3 references)

PMID:22777259 SUPPORT Human Clinical

"CLIPPERS is a relapsing-remitting disorder without progressive forms. Long-term disability is correlated with the severity of previous relapses."

States both halves of the course this phase records: no progressive form, and disability driven by relapse severity.

PMID:22777259 SUPPORT Human Clinical

"Four patients with a final EDSS score of 4 or higher had experienced previous severe relapses (EDSS score, ≥5) and brainstem and spinal cord atrophy."

Links the residual disability to prior relapse severity and to structural atrophy, which is the anatomical end point of the tissue-injury node in the pathograph.

PMID:22777259 SUPPORT Human Clinical

"In 1 patient with untreated relapses, scores on the EDSS progressively increased to a score of 10 at death."

The untreated course, from the only patient in the series who had one. A single patient, so it is recorded as the observation it is rather than as a rate.

📊

Prevalence

1

Worldwide

Cases In Literature Unknown

No population rate has been estimated and none exists in Orphanet or any registry. The largest synthesis is a systematic review that found 140 patients across 100 case reports and series published between the 2010 first description and January 2022. That count is the whole recorded world literature, not a sample of it, so it measures recognition rather than occurrence.

Show evidence (2 references)

PMID:36029706 SUPPORT Human Clinical

"We identified 100 case reports and series including a total of 140 patients with CLIPPERS (mean age: 46±18 years and males were 60%)."

Gives the size of the entire published literature, together with the age and sex distribution, which is the basis for recording occurrence as a literature case count.

PMID:29050399 SUPPORT Human Clinical

"CLIPPERS was diagnosed in 23 patients (18 male and five female) and 12 patients had a non-CLIPPERS diagnosis."

Gives the largest single-centre confirmed count, and simultaneously the proportion of referrals that are not the disease, which is why any count reflects ascertainment.

⚖️

Clinical Burden

High

Revised upward from the impression the founding cohort gives. Across the whole published literature the relapse rate is 59.2% and overall mortality is 10%, rising to 30% in the patients whose CLIPPERS is associated with malignancy. Every reported patient worsens when corticosteroids are withdrawn, so treatment is indefinite with the cumulative toxicity that implies, and repeated untreated attacks produce brainstem and cerebellar atrophy with permanent disability. A tenth of patients dying, in a condition usually described as steroid-responsive, is what places this at HIGH rather than MODERATE.

Show evidence (4 references)

PMID:36029706 SUPPORT Human Clinical

"The overall mortality rate was 10%, but mortality in patients with malignancy was 30% and it was 12% in patients with relapses."

Gives the mortality figures overall and stratified by malignancy association, the principal basis for the HIGH burden assessment.

PMID:36029706 SUPPORT Human Clinical

"The overall relapse rate was 59.2%, and the duration of steroid therapy was considerably shorter in the relapsed cases than in the non-relapsed"

Quantifies relapse and links it to the duration of the acute steroid course, which is the modifiable part of the burden.

PMID:28110629 SUPPORT Human Clinical

"Long-term immunosuppression appears to be mandatory in order to achieve sustained remission and prevent disability related to atrophy of the structures involved in repeated attacks."

States the mechanism by which relapses convert into permanent disability - atrophy of the repeatedly inflamed structures - and the indefinite treatment it forces.

+ 1 more reference

{ }

Source YAML

click to show

name: Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive To Steroids
creation_date: "2026-09-18T00:00:00Z"
category: Complex
synonyms:
- CLIPPERS
- CLIPPERS syndrome
- chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids syndrome
description: >
  CLIPPERS is a chronic inflammatory disorder of the central nervous system that centres on
  the brainstem. It was defined in 2010 from eight patients as a triad: a clinical syndrome
  of episodic diplopia, facial paraesthesia and gait ataxia progressing to brainstem and
  sometimes myelopathic signs; a distinctive MRI appearance of symmetric curvilinear
  gadolinium enhancement "peppering" the pons and extending into medulla, middle cerebellar
  peduncles, cerebellum, midbrain and occasionally cord; and a perivascular, predominantly
  T-lymphocytic white-matter infiltrate on biopsy, without granulomas, organisms, lymphoma
  or vasculitis. Clinical and radiological response to high-dose glucocorticosteroids is
  marked, and relapse on taper is the rule rather than the exception, so patients need
  chronic immunosuppression.

  The name is a description, not a mechanism, and that is the honest state of the disease.
  The T-cell-predominant pathology and the corticosteroid responsiveness are together taken
  as evidence of an immune-mediated process, but no antigen, autoantibody, infectious
  trigger or genetic susceptibility locus has been established, and no diagnostic biomarker
  exists. This entry therefore models the pathograph from the earliest node anyone has
  actually observed - perivascular T-cell infiltration of brainstem white matter - and
  records the missing upstream trigger as an explicit knowledge gap rather than supplying a
  plausible one.

  CLIPPERS is also a diagnosis of exclusion with a documented and consequential mimic
  problem. Formal criteria published in 2017 were motivated by reports of dissimilar
  patients labelled CLIPPERS, and in that series 12 of 35 patients referred with suspected
  CLIPPERS had another diagnosis. Corticosteroid responsiveness does not settle it: most of
  the non-CLIPPERS patients improved on steroids too. Individual patients with textbook
  presentations have declared themselves months to years later as CNS B-cell lymphoma.
  Follow-up dependency is therefore part of the disease definition, not an afterthought.
disease_term:
  preferred_term: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids
  term:
    id: MONDO:0017297
    label: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids
parents:
- Central nervous system inflammatory disease
references:
- reference: PMID:20639547
  title: "Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
- reference: PMID:29050399
  title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
- reference: PMID:23649857
  title: "Fatal B-cell lymphoma following chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids."
- reference: PMID:35126669
  title: "Brain biopsy in patients with CLIPPERS syndrome: why and when."
- reference: PMID:23706003
  title: "Need for prolonged immunosupressive therapy in CLIPPERS--a case report."
- reference: PMID:36029706
  title: "Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies."
- reference: PMID:33658321
  title: "Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome."
- reference: PMID:41781714
  title: "Two Cases of CLIPPERS-like Syndrome Sharing a Hypomorphic UNC13D Variant."
- reference: PMID:28110629
  title: "CLIPPERS and the need for long-term immunosuppression."
- reference: PMID:27861371
  title: "Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) with intracranial Epstein-Barr virus infection: A Case Report."
notes: >-
  No GeneReviews chapter applies: CLIPPERS is not a Mendelian disorder and no causal gene
  is known. `just check-genereviews` returns NO_CHAPTER for both collections against the
  committed Bookshelf index (snapshot 2026-09-10). The phenotype baseline used here is the
  2017 diagnostic-criteria series (PMID:29050399) together with the original 2010 cohort
  (PMID:20639547).
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: UNKNOWN
  notes: >-
    No population rate has been estimated and none exists in Orphanet or any registry. The
    largest synthesis is a systematic review that found 140 patients across 100 case reports
    and series published between the 2010 first description and January 2022. That count is
    the whole recorded world literature, not a sample of it, so it measures recognition
    rather than occurrence.
  evidence:
  - reference: PMID:36029706
    reference_title: "Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified 100 case reports and series including a total of 140 patients with
      CLIPPERS (mean age: 46±18 years and males were 60%).
    explanation: >-
      Gives the size of the entire published literature, together with the age and sex
      distribution, which is the basis for recording occurrence as a literature case count.
  - reference: PMID:29050399
    reference_title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      CLIPPERS was diagnosed in 23 patients (18 male and five female) and 12 patients had a
      non-CLIPPERS diagnosis.
    explanation: >-
      Gives the largest single-centre confirmed count, and simultaneously the proportion of
      referrals that are not the disease, which is why any count reflects ascertainment.
progression:
- phase: Relapse
  duration: mean 2.5 months
  notes: >-
    Relapses are discrete and self-limited in duration but not in consequence: the mean
    Expanded Disability Status Scale score during a relapse in the French nationwide series
    was 4, and the residual score after pulse corticosteroid treatment was 1.9. The gap
    between those two numbers is what maintenance therapy is for.
  evidence:
  - reference: PMID:22777259
    reference_title: "Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Relapses lasted a mean duration of 2.5 months, manifested frequent cerebellar ataxia
      and diplopia, and were associated with a mean Expanded Disability Status Scale (EDSS)
      score of 4
    explanation: >-
      Gives the duration and the disability level of a relapse, which is what this phase
      records.
- phase: Long-term course
  notes: >-
    Relapsing-remitting, with no progressive phase described. Disability therefore accrues
    stepwise from the severity of individual relapses rather than accumulating between them,
    and the patients who ended with a high residual score are the ones who had had severe
    relapses and who show brainstem and spinal cord atrophy on imaging. This is the
    structural reason the entry treats delayed or withheld treatment as the thing that
    determines outcome: the one untreated patient in the series reached a score of 10.
  evidence:
  - reference: PMID:22777259
    reference_title: "Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      CLIPPERS is a relapsing-remitting disorder without progressive forms. Long-term
      disability is correlated with the severity of previous relapses.
    explanation: >-
      States both halves of the course this phase records: no progressive form, and
      disability driven by relapse severity.
  - reference: PMID:22777259
    reference_title: "Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Four patients with a final EDSS score of 4 or higher had experienced previous severe
      relapses (EDSS score, ≥5) and brainstem and spinal cord atrophy.
    explanation: >-
      Links the residual disability to prior relapse severity and to structural atrophy,
      which is the anatomical end point of the tissue-injury node in the pathograph.
  - reference: PMID:22777259
    reference_title: "Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In 1 patient with untreated relapses, scores on the EDSS progressively increased to a
      score of 10 at death.
    explanation: >-
      The untreated course, from the only patient in the series who had one. A single
      patient, so it is recorded as the observation it is rather than as a rate.
clinical_burden:
  burden_level: HIGH
  rationale: >-
    Revised upward from the impression the founding cohort gives. Across the whole published
    literature the relapse rate is 59.2% and overall mortality is 10%, rising to 30% in the
    patients whose CLIPPERS is associated with malignancy. Every reported patient worsens
    when corticosteroids are withdrawn, so treatment is indefinite with the cumulative
    toxicity that implies, and repeated untreated attacks produce brainstem and cerebellar
    atrophy with permanent disability. A tenth of patients dying, in a condition usually
    described as steroid-responsive, is what places this at HIGH rather than MODERATE.
  evidence:
  - reference: PMID:36029706
    reference_title: "Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The overall mortality rate was 10%, but mortality in patients with malignancy was 30%
      and it was 12% in patients with relapses.
    explanation: >-
      Gives the mortality figures overall and stratified by malignancy association, the
      principal basis for the HIGH burden assessment.
  - reference: PMID:36029706
    reference_title: "Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The overall relapse rate was 59.2%, and the duration of steroid therapy was
      considerably shorter in the relapsed cases than in the non-relapsed
    explanation: >-
      Quantifies relapse and links it to the duration of the acute steroid course, which is
      the modifiable part of the burden.
  - reference: PMID:28110629
    reference_title: "CLIPPERS and the need for long-term immunosuppression."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Long-term immunosuppression appears to be mandatory in order to achieve sustained
      remission and prevent disability related to atrophy of the structures involved in
      repeated attacks.
    explanation: >-
      States the mechanism by which relapses convert into permanent disability - atrophy of
      the repeatedly inflamed structures - and the indefinite treatment it forces.
  - reference: PMID:29050399
    reference_title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      clinical worsening occurred in all 12 CLIPPERS cases when corticosteroids were
      discontinued
    explanation: >-
      Establishes the universal relapse on withdrawal that makes treatment indefinite.
genetic:
- name: PRF1
  gene_term:
    preferred_term: PRF1
    term:
      id: hgnc:9360
      label: PRF1
  relationship_type: SUSCEPTIBILITY
  notes: >
    Biallelic PRF1 mutations with reduced perforin expression in natural killer cells were
    found in three of twelve adult CLIPPERS patients who consented to genetic testing. None
    met systemic HLH criteria. Recorded as SUSCEPTIBILITY rather than CAUSATIVE because it
    remains unsettled whether these patients have CLIPPERS with a genetic modifier or a
    distinct, HLH-spectrum disease that presents as CLIPPERS - see the discussion attached
    to this entry.
  evidence:
  - reference: PMID:33658321
    reference_title: "Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Three of them had biallelic PRF1 mutations with reduced perforin expression in natural
      killer cells.
    explanation: >-
      Documents biallelic PRF1 mutations with a demonstrated protein-level consequence in
      adult CLIPPERS patients.
- name: UNC13D
  gene_term:
    preferred_term: UNC13D
    term:
      id: hgnc:23147
      label: UNC13D
  relationship_type: SUSCEPTIBILITY
  notes: >
    Biallelic UNC13D mutations with impaired cytotoxic lymphocyte degranulation were found
    in a fourth adult CLIPPERS patient, and an independent report describes two further
    patients sharing a hypomorphic UNC13D variant in compound heterozygosity. UNC13D encodes
    Munc13-4, required for cytotoxic granule fusion - the same step perforin acts at, one
    stage earlier.
  evidence:
  - reference: PMID:33658321
    reference_title: "Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The remaining patient had biallelic UNC13D mutations with cytotoxic lymphocyte
      impaired degranulation.
    explanation: >-
      Documents biallelic UNC13D mutations with a functional degranulation defect in an
      adult CLIPPERS patient.
  - reference: PMID:41781714
    reference_title: "Two Cases of CLIPPERS-like Syndrome Sharing a Hypomorphic UNC13D Variant."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report two patients with CLIPPERS-like brain MRI findings who carried the same
      missense UNC13D variant in one allele along with deleterious variants in the opposite
      allele.
    explanation: >-
      Independently replicates the UNC13D association in two further patients, which is what
      moves it beyond a single-cohort observation.
mechanistic_hypotheses:
- hypothesis_group_id: failed_cytotoxic_clearance
  hypothesis_label: Failed cytotoxic clearance sustains the infiltrate
  status: EMERGING
  description: >-
    That in at least a subgroup, CLIPPERS is driven by an inability of cytotoxic lymphocytes
    to kill. Biallelic PRF1 or UNC13D lesions leave an antigen-bearing target uncleared, so
    the T cell response against it never resolves and becomes the chronic perivascular
    infiltrate that defines the disease. The attraction of this model is that it explains
    the chronicity - a feature the "immune-mediated inflammation" account merely restates -
    and it predicts the steroid dependence, since suppression removes the response without
    removing its stimulus. It is EMERGING rather than established: the association rests on
    4 of 12 tested patients in one cohort plus two further UNC13D patients, no step between
    the degranulation defect and the brainstem lesion has been traced, and three of the four
    mutated patients subsequently showed features atypical for CLIPPERS.
  evidence:
  - reference: PMID:33658321
    reference_title: "Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In our patients presenting with adult-onset CLIPPERS, one-third have HLH gene
      mutations. This genetic treatable condition should be searched in patients with
      CLIPPERS, especially in those presenting with atypical findings.
    explanation: >-
      States the frequency the hypothesis rests on and the authors' own clinical reading of
      it, including the qualifier that the association is strongest in atypical cases.
pathophysiology:
- name: Impaired Cytotoxic Lymphocyte Granule-Mediated Killing
  description: >
    Present in a genetic subgroup rather than in every patient. Roughly a third of adult
    CLIPPERS patients tested carry biallelic mutations in primary HLH genes - PRF1, whose
    product perforin punctures the target-cell membrane, or UNC13D, whose product Munc13-4
    is required one step earlier for cytotoxic granule fusion. Both lesions converge on the
    same failure: cytotoxic lymphocytes cannot kill. The proposed consequence is that
    antigen-bearing target cells are not cleared, so the T cell response against them
    persists instead of resolving - which would make the chronic perivascular infiltrate a
    consequence of failed killing rather than of excessive activation.

    Two things keep this node hypothetical rather than established. None of the mutated
    patients met systemic HLH criteria, so this is not simply HLH presenting in the brain.
    And three of the four went on to show findings atypical for CLIPPERS, one developing
    systemic non-Hodgkin lymphoma - which leaves open whether they had CLIPPERS at all.
  biological_scale: CELLULAR
  mechanism_confidence: HYPOTHETICAL
  cell_types:
  - preferred_term: natural killer cell
    term:
      id: CL:0000623
      label: natural killer cell
  - preferred_term: cytotoxic T cell
    term:
      id: CL:0000910
      label: cytotoxic T cell
  biological_processes:
  - preferred_term: natural killer cell mediated cytotoxicity
    modifier: DECREASED
    term:
      id: GO:0042267
      label: natural killer cell mediated cytotoxicity
  - preferred_term: regulated exocytosis of cytotoxic granules
    modifier: DECREASED
    term:
      id: GO:0045055
      label: regulated exocytosis
  genes:
  - preferred_term: PRF1
    term:
      id: hgnc:9360
      label: PRF1
  - preferred_term: UNC13D
    term:
      id: hgnc:23147
      label: UNC13D
  downstream:
  - target: Perivascular T-Lymphocytic Infiltration of Brainstem White Matter
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    hypothesis_groups:
    - failed_cytotoxic_clearance
    description: >-
      Proposed rather than demonstrated: failed cytotoxic clearance of an antigen-bearing
      target is suggested to sustain the T cell infiltrate. No study has traced the steps
      between the degranulation defect and the brainstem lesion.
    evidence:
    - reference: PMID:33658321
      reference_title: "Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        To determine whether adult cases of Chronic Lymphocytic Inflammation with Pontine
        Perivascular Enhancement Responsive to Steroids (CLIPPERS) may be related to
        familial hemophagocytic lymphohistiocytosis (HLH) causes, we have screened patients
        with adult-onset CLIPPERS for mutations in primary HLH-associated genes.
      explanation: >-
        States the hypothesis this edge encodes. Graded INDIRECT because the study
        establishes an association between the genotype and the syndrome, not the causal
        path from degranulation failure to the brainstem infiltrate.
  evidence:
  - reference: PMID:33658321
    reference_title: "Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Mutations involved in HLH were identified in 2 definite and 2 probable CLIPPERS (4/12).
    explanation: >-
      Quantifies how often this node applies: a third of the tested adult patients, not all
      of them.
  - reference: PMID:33658321
    reference_title: "Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      None of the mutated patients reached the criteria for systemic HLH.
    explanation: >-
      Establishes that this is not systemic HLH with brain involvement, which is what makes
      the node a distinct proposal rather than a reclassification.
- name: Perivascular T-Lymphocytic Infiltration of Brainstem White Matter
  description: >
    The earliest event anyone has observed. Biopsy of affected brainstem white matter shows
    a dense perivascular infiltrate dominated by CD3-positive T lymphocytes, with mild
    B-lymphocyte and moderate macrophage components, present in meninges and in both white
    and grey matter. Granulomas, organisms, lymphoma and vasculitis are absent, which is
    what distinguishes the finding rather than what explains it. What recruits these cells,
    and against what, is unknown - see the knowledge gap attached to this node.

    The T-cell predominance in this node's name is the finding of the founding and
    criteria-defining cohorts, and it is contested: a six-patient Chinese series found the
    infiltrate dominated by CD20-positive B cells in three of the four biopsies that showed
    an infiltrate at all. The node keeps its name because the larger cohorts support it, but
    the lineage should be read as the majority finding rather than a settled one. The
    contradiction is recorded as a REFUTE item below and in the
    clippers_infiltrate_lineage_contested discussion.
  biological_scale: TISSUE
  cell_types:
  - preferred_term: CD3-positive T lymphocyte
    term:
      id: CL:0000084
      label: T cell
  - preferred_term: B lymphocyte
    term:
      id: CL:0000236
      label: B cell
  - preferred_term: macrophage
    term:
      id: CL:0000235
      label: macrophage
  locations:
  - preferred_term: brainstem white matter
    term:
      id: UBERON:0014891
      label: brainstem white matter
  biological_processes:
  - preferred_term: T cell migration into brainstem white matter
    modifier: INCREASED
    term:
      id: GO:0072678
      label: T cell migration
  downstream:
  - target: Blood-Brain Barrier Breakdown at Pontine Perforating Vessels
    causal_link_type: DIRECT
    description: >-
      The perivascular location of the infiltrate is what makes the enhancement pattern
      perivascular: inflammation sits on the small perforating vessels of the pons.
    evidence:
    - reference: PMID:20639547
      reference_title: "Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Neuropathology of biopsy material from four patients demonstrated white matter
        perivascular, predominantly T lymphocytic, infiltrate without granulomas,
        infection, lymphoma or vasculitis.
      explanation: >-
        Locates the infiltrate perivascularly in white matter, which is the anatomical fact
        that the enhancement pattern in the next node reports.
  - target: Inflammatory Tissue Injury with Astrogliosis and Secondary Myelin Loss
    causal_link_type: DIRECT
    evidence:
    - reference: PMID:29050399
      reference_title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        with perivascular predominance as well as diffuse parenchymal infiltration (14/14),
        present in meninges, white and grey matter, associated with variable tissue
        destruction, astrogliosis and secondary myelin loss
      explanation: >-
        States the association between the infiltrate and the tissue injury in the same
        clause, which is the claim this edge makes rather than either node alone.
  evidence:
  - reference: PMID:33498046
    reference_title: "Increased Number of Perivascular CD20-Positive B Lymphocytes in the Neuropathology of CLIPPERS: Findings of 6 Patients from Mainland China."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the other 3 patients were dominated by CD20+ B cell infiltration
    explanation: >-
      Contradicts the T-cell predominance this node is named for. Three of the four
      informative biopsies in this series were B-cell dominant, so the lineage claim is not
      settled; graded REFUTE against this node rather than quietly folded into it.
  - reference: PMID:33498046
    reference_title: "Increased Number of Perivascular CD20-Positive B Lymphocytes in the Neuropathology of CLIPPERS: Findings of 6 Patients from Mainland China."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the lymphocytic infiltration in the lesions of CLIPPERS may be dominated by CD20+ B
      cells instead of CD3+ T cells
    explanation: >-
      The authors' own statement of the conclusion, which is what makes this a claim about
      the disease rather than an incidental observation in one series.
  - reference: PMID:29050399
    reference_title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Brain neuropathology on 14 CLIPPERS cases demonstrated marked CD3-positive
      T-lymphocyte, mild B-lymphocyte and moderate macrophage infiltrates
    explanation: >-
      Gives the cellular composition of the infiltrate, in the largest biopsied series, and
      the relative weighting of the three populations bound on this node.
- name: Blood-Brain Barrier Breakdown at Pontine Perforating Vessels
  description: >
    Inflammation of the small perforating vessels makes them leak gadolinium, producing the
    radiological signature of the disease: symmetric, curvilinear and punctate enhancement
    peppering the pons. The 2017 criteria sharpened this into discriminating features -
    homogeneous enhancing nodules under 3 mm without ring enhancement or mass effect, and
    T2 signal abnormality not significantly exceeding the T1 enhancement. Those two
    negatives are what separate the pattern from lymphoma and from demyelinating disease.
  biological_scale: TISSUE
  locations:
  - preferred_term: pons
    term:
      id: UBERON:0000988
      label: pons
  downstream:
  - target: Pontine perivascular gadolinium enhancement
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:29050399
    reference_title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      CLIPPERS patients had brainstem predominant perivascular gadolinium enhancing lesions
      on magnetic resonance imaging that were discriminated from non-CLIPPERS by:
      homogenous gadolinium enhancing nodules <3 mm in diameter without ring-enhancement or
      mass effect, and homogenous T2 signal abnormality not significantly exceeding the T1
      enhancement.
    explanation: >-
      Gives the enhancement characteristics produced by this node, including the two
      negative features that carry the discriminating power.
- name: Inflammatory Tissue Injury with Astrogliosis and Secondary Myelin Loss
  description: >
    Sustained infiltration produces variable tissue destruction, reactive astrogliosis and
    secondary myelin loss. The myelin loss is explicitly secondary - this is not a primary
    demyelinating disease - which matters for both classification and for reading the MRI.
  biological_scale: TISSUE
  cell_types:
  - preferred_term: astrocyte
    term:
      id: CL:0000127
      label: astrocyte
  biological_processes:
  - preferred_term: reactive gliosis
    modifier: INCREASED
    term:
      id: GO:0150103
      label: reactive gliosis
  downstream:
  - target: Brainstem and Cerebellar Dysfunction
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:29050399
    reference_title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      associated with variable tissue destruction, astrogliosis and secondary myelin loss
    explanation: >-
      Names the three components of tissue injury this node asserts, and marks the myelin
      loss as secondary.
- name: Brainstem and Cerebellar Dysfunction
  description: >
    Injury in the pons, middle cerebellar peduncles and cerebellum produces the clinical
    syndrome: diplopia from ocular motor involvement, facial paraesthesia from trigeminal
    tract involvement, and gait ataxia from cerebellar and peduncular involvement, with
    myelopathic signs when the cord is affected.
  biological_scale: ORGANISM
  locations:
  - preferred_term: brainstem
    term:
      id: UBERON:0002298
      label: brainstem
  downstream:
  - target: Diplopia
    causal_link_type: DIRECT
  - target: Dysarthria
    causal_link_type: DIRECT
  - target: Facial paraesthesia
    causal_link_type: DIRECT
  - target: Gait ataxia
    causal_link_type: DIRECT
  - target: Myelopathy
    causal_link_type: DIRECT
  - target: Cognitive impairment
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:20639547
    reference_title: "Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All eight patients (five female, three male) presented with episodic diplopia or
      facial paresthesias with subsequent brainstem and occasionally myelopathic symptoms
    explanation: >-
      Maps the anatomical site of injury onto the presenting clinical syndrome this node
      produces.
phenotypes:
- category: Neurological
  name: Diplopia
  description: >
    Double vision from ocular motor involvement in the pons and midbrain. With facial
    paraesthesia it is one of the two typical presenting symptoms.
  phenotype_term:
    preferred_term: Diplopia
    term:
      id: HP:0000651
      label: Diplopia
  frequency: FREQUENT
  evidence:
  - reference: PMID:20639547
    reference_title: "Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All eight patients (five female, three male) presented with episodic diplopia or
      facial paresthesias
    explanation: >-
      Documents diplopia as a presenting feature across the founding cohort.
  - reference: PMID:22777259
    reference_title: "Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      manifested frequent cerebellar ataxia and diplopia
    explanation: >-
      An independent nationwide series calling diplopia frequent across 42 relapses, which
      is the anchor for the FREQUENT band rather than the presenting-feature sentence above.
  notes: >-
    The band is qualitative. No published series reports a percentage for diplopia in
    CLIPPERS; FREQUENT rests on two cohorts describing it as a typical or frequent feature.
- category: Neurological
  name: Facial paraesthesia
  description: >
    Abnormal facial sensation from involvement of trigeminal pathways in the pons, the
    other typical presenting symptom. It is not discriminating on its own - the 2017 series
    found it equally common in patients who turned out not to have CLIPPERS.
  phenotype_term:
    preferred_term: Paresthesia
    term:
      id: HP:0003401
      label: Paresthesia
  frequency: FREQUENT
  evidence:
  - reference: PMID:29050399
    reference_title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinical symptoms of gait ataxia, diplopia, cognitive impairment, and facial
      paraesthesia did not discriminate CLIPPERS from non-CLIPPERS.
    explanation: >-
      Documents facial paraesthesia as a feature of the syndrome while recording explicitly
      that it carries no discriminating value, which is the more useful fact. It says
      nothing about frequency, which is why the band needs the item below.
  - reference: PMID:33498046
    reference_title: "Increased Number of Perivascular CD20-Positive B Lymphocytes in the Neuropathology of CLIPPERS: Findings of 6 Patients from Mainland China."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The common clinical manifestations included ataxia, dysarthria, diplopia, dysphagia,
      dizziness, cognitive impairment, facial paresthesia, and paralysis.
    explanation: >-
      Names facial paraesthesia among the common manifestations, which is the frequency
      anchor for the band. A six-patient series, so it supports a qualitative band and not
      a rate.
  notes: >-
    The band is qualitative, from one six-patient series describing the feature as common.
    No series reports a percentage.
- category: Neurological
  name: Gait ataxia
  description: >
    Unsteady gait from cerebellar and middle cerebellar peduncle involvement. Like the other
    clinical features it is characteristic of the syndrome but does not distinguish it from
    its mimics.
  phenotype_term:
    preferred_term: Gait ataxia
    term:
      id: HP:0002066
      label: Gait ataxia
  frequency: FREQUENT
  evidence:
  - reference: PMID:29050399
    reference_title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinical symptoms of gait ataxia, diplopia, cognitive impairment, and facial
      paraesthesia did not discriminate CLIPPERS from non-CLIPPERS.
    explanation: >-
      Records gait ataxia among the syndrome's clinical features, and its lack of
      discriminating value. It carries no frequency information, which the item below
      supplies.
  - reference: PMID:36029706
    reference_title: "Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Ataxia was the most common presenting symptom.
    explanation: >-
      The frequency anchor for this band, from the 140-patient systematic review. It ranks
      ataxia first among presenting symptoms without giving a percentage, which is why the
      band stays qualitative.
  notes: >-
    Ataxia is the most common presenting symptom across the 140 published cases, but no
    source gives a rate, so the band is FREQUENT on a qualitative ranking rather than on a
    proportion.
- category: Neurological
  name: Dysarthria
  description: >
    Cerebellar dysarthria from involvement of the pons and middle cerebellar peduncles. With
    diplopia and gait ataxia it completes the brainstem-cerebellar picture the syndrome is
    defined by, and it was the omission this entry's first round was blocked on.
  phenotype_term:
    preferred_term: Cerebellar dysarthria
    term:
      id: HP:0001260
      label: Dysarthria
  frequency: FREQUENT
  evidence:
  - reference: PMID:36029706
    reference_title: "Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      characterized by symptoms referable to the brainstem and cerebellum such as, diplopia,
      gait ataxia and cerebellar dysarthria
    explanation: >-
      Names cerebellar dysarthria as one of the three defining symptoms of the syndrome.
      quote_role REVIEW_SYNTHESIS because the citing publication is a systematic review and
      this sentence is its characterisation of a clinical picture drawn from the cases it
      pooled, rather than a measurement it made.
  - reference: PMID:33498046
    reference_title: "Increased Number of Perivascular CD20-Positive B Lymphocytes in the Neuropathology of CLIPPERS: Findings of 6 Patients from Mainland China."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The common clinical manifestations included ataxia, dysarthria, diplopia, dysphagia,
      dizziness, cognitive impairment, facial paresthesia, and paralysis.
    explanation: >-
      An independent series listing dysarthria among the common manifestations, which is the
      frequency anchor for the band.
  notes: >-
    Bound to HP:0001260 Dysarthria rather than to a cerebellar-specific term. The cerebellar
    qualifier is carried in preferred_term because the sources describe cerebellar
    dysarthria specifically, while the HPO term for the sign itself is unqualified.
- category: Neurological
  name: Cognitive impairment
  description: >
    Cognitive dysfunction, reported among the clinical features evaluated in the
    diagnostic-criteria series. Like the other symptoms it did not separate CLIPPERS from
    non-CLIPPERS aetiologies.
  phenotype_term:
    preferred_term: Cognitive impairment
    term:
      id: HP:0100543
      label: Cognitive impairment
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:29050399
    reference_title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Clinical symptoms of gait ataxia, diplopia, cognitive impairment, and facial
      paraesthesia did not discriminate CLIPPERS from non-CLIPPERS.
    explanation: >-
      Records cognitive impairment among the evaluated clinical features of the syndrome. It
      says nothing about how often it occurs.
  - reference: PMID:33498046
    reference_title: "Increased Number of Perivascular CD20-Positive B Lymphocytes in the Neuropathology of CLIPPERS: Findings of 6 Patients from Mainland China."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The common clinical manifestations included ataxia, dysarthria, diplopia, dysphagia,
      dizziness, cognitive impairment, facial paresthesia, and paralysis.
    explanation: >-
      The only source that calls cognitive impairment common. Recorded, but not treated as
      sufficient to raise the band - see notes.
  notes: >-
    Left at OCCASIONAL rather than raised. The one source describing cognitive impairment as
    a common manifestation is a six-patient series; the larger cohorts list it among the
    features evaluated without stating how often it occurred, and the 140-patient systematic
    review ranks only ataxia. Raising the band on six patients would assert more than the
    literature supports.
- category: Neurological
  name: Myelopathy
  description: >
    Spinal cord involvement, occurring in a minority and following brainstem onset. The
    enhancement pattern extends into the cord in the same patients.
  phenotype_term:
    preferred_term: Myelopathy
    term:
      id: HP:0002196
      label: Myelopathy
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:20639547
    reference_title: "Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      with subsequent brainstem and occasionally myelopathic symptoms
    explanation: >-
      Documents myelopathic involvement as an occasional and subsequent rather than
      presenting feature.
- category: Imaging
  name: Pontine perivascular gadolinium enhancement
  description: >
    The radiological signature: symmetric curvilinear and punctate gadolinium enhancement
    peppering the pons and extending into medulla, middle cerebellar peduncle, cerebellum,
    midbrain and occasionally cord. Unlike the clinical features, this is discriminating -
    provided the size and T2 constraints from the 2017 criteria are applied.
  phenotype_term:
    preferred_term: Abnormal brainstem MRI signal intensity
    term:
      id: HP:0012747
      label: Abnormal brainstem MRI signal intensity
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:20639547
    reference_title: "Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All patients had symmetric curvilinear gadolinium enhancement peppering the pons and
      extending variably into the medulla, brachium pontis, cerebellum, midbrain and
      occasionally spinal cord.
    explanation: >-
      Documents the enhancement pattern and its anatomical distribution in every patient of
      the founding cohort.
diagnosis:
- name: Contrast-enhanced brain MRI with size and T2 constraints
  description: >
    MRI is the discriminating test, but only when read against the 2017 criteria rather than
    for the enhancement pattern alone: enhancing nodules must be under 3 mm, without ring
    enhancement or mass effect, and the T2 abnormality must not significantly exceed the T1
    enhancement. Those constraints exist because the gross pattern alone had been letting
    other diseases in.
  evidence:
  - reference: PMID:29050399
    reference_title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the lack of formalized diagnostic criteria has led to reports of patients with
      dissimilar features purported to have CLIPPERS
    explanation: >-
      States the problem the quantitative imaging constraints were written to solve, which
      is why the constraints rather than the pattern are the diagnostic content.
- name: Brain biopsy
  description: >
    Biopsy shows the perivascular CD3-positive T-cell infiltrate and, critically, excludes
    lymphoma, granulomatous disease, infection and vasculitis. Because no biomarker exists
    and because CNS lymphoma has repeatedly declared itself late in patients who initially
    met every CLIPPERS criterion, there is a published argument for biopsying early rather
    than after steroid failure.
  evidence:
  - reference: PMID:35126669
    reference_title: "Brain biopsy in patients with CLIPPERS syndrome: why and when."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hence, we propose that in the absence of other diagnostic markers, brain biopsy should
      be performed as early as possible in CLIPPERS patients.
    explanation: >-
      States the case for early biopsy and its premise - the absence of any diagnostic
      marker - which is the reason this test carries the diagnostic weight it does.
  - reference: PMID:35126669
    reference_title: "Brain biopsy in patients with CLIPPERS syndrome: why and when."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Yet diagnostic biomarkers are missing and other immune-mediated, (para-) infectious
      and malignant causes mimic CLIPPERS-like MRI presentations.
    explanation: >-
      Records that no biomarker exists and that the MRI appearance is mimicked by several
      disease classes, which is what leaves biopsy as the discriminating test.
- name: Cerebrospinal fluid examination
  description: >
    CSF is examined to exclude infection and to characterise the inflammation, not to
    confirm the diagnosis: the findings are mild and inconstant. Oligoclonal bands appear in
    a minority, and the lymphocyte population shows the raised CD4:CD8 ratio consistent with
    the CD4-predominant perivascular infiltrate seen on biopsy. A normal CSF does not argue
    against CLIPPERS.
  evidence:
  - reference: PMID:22777259
    reference_title: "Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Inconstant oligoclonal bands were found on cerebrospinal fluid investigation in 4
      patients, with an increased T-cell ratio of CD4 to CD8.
    explanation: >-
      Gives both findings and, in the word inconstant, the reason this test cannot confirm
      or exclude the diagnosis.
- name: Screening for occult malignancy
  description: >
    Not a test for CLIPPERS but a test that must accompany it. Sixteen percent of published
    cases carry an associated malignancy, mostly haematological, and mortality in that group
    is three times the overall figure. The systematic review makes the recommendation
    explicitly, and it is the practical consequence of the entity-versus-syndrome question
    recorded in this entry's discussions.
  evidence:
  - reference: PMID:36029706
    reference_title: "Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These patients should be screened for associated malignancies, especially
      hematological malignancies.
    explanation: >-
      The recommendation itself, from the largest pooled series.
  - reference: PMID:36029706
    reference_title: "Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The overall mortality rate was 10%, but mortality in patients with malignancy was 30%
      and it was 12% in patients with relapses.
    explanation: >-
      Quantifies why the screening matters: an associated malignancy triples mortality.
treatments:
- name: High-Dose Glucocorticosteroid Therapy
  description: >
    High-dose corticosteroids produce a marked clinical and radiological response, and in
    the 2017 series this was universal - 23 of 23 confirmed patients. It is not by itself a
    diagnostic test: 8 of 12 patients who turned out to have another disease also improved
    clinically on steroids, and the discriminating feature was radiological response, seen
    in only 2 of those 12.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: glucocorticoid
      term:
        id: CHEBI:24261
        label: glucocorticoid
  target_mechanisms:
  - target: Perivascular T-Lymphocytic Infiltration of Brainstem White Matter
    description: >-
      Corticosteroids suppress the T-cell infiltrate directly; the radiological and clinical
      improvement follows from that.
  evidence:
  - reference: PMID:29050399
    reference_title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Marked clinical and radiological corticosteroid responsiveness was observed in
      CLIPPERS (23/23)
    explanation: >-
      Establishes universal corticosteroid responsiveness in the confirmed cohort.
  - reference: PMID:29050399
    reference_title: "Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Corticosteroid responsiveness was common but not universal in non-CLIPPERS [clinical
      improvement (8/12); radiological improvement (2/12); clinical worsening on
      discontinuation (3/8)].
    explanation: >-
      Records that steroid response occurs in the mimics too, which is why responsiveness
      cannot stand as a diagnostic criterion on its own despite being in the disease name.
- name: Chronic Steroid-Sparing Immunosuppression
  description: >
    Because relapse on taper is universal, patients require indefinite maintenance therapy,
    with steroid-sparing agents such as methotrexate used to limit cumulative corticosteroid
    toxicity. The evidence base is case series and case reports; there is no controlled
    trial and no agreed regimen.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Immunosuppressive Therapy
    term:
      id: NCIT:C15261
      label: Immunosuppressive Therapy
    therapeutic_agent:
    - preferred_term: methotrexate
      term:
        id: CHEBI:44185
        label: methotrexate
  target_mechanisms:
  - target: Perivascular T-Lymphocytic Infiltration of Brainstem White Matter
    description: >-
      Maintenance immunosuppression holds the same infiltrate suppressed once corticosteroids
      are withdrawn.
  evidence:
  - reference: PMID:20639547
    reference_title: "Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients routinely worsened following glucocorticosteroid taper and required chronic
      glucocorticosteroid or other immunosuppressive therapy.
    explanation: >-
      Establishes the need for chronic immunosuppression as a consequence of universal
      taper-dependent relapse.
  - reference: PMID:36029706
    reference_title: "Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The overall relapse rate was 59.2%, and the duration of steroid therapy was
      considerably shorter in the relapsed cases than in the non-relapsed (mean 6.19±7.9 vs.
      10.14±12.1 days, respectively, P = 0.04)
    explanation: >-
      The only quantitative handle on how to give the treatment: relapse tracked with a
      shorter acute course, not with the dose. Note the comparison is observational across
      pooled case reports, so it cannot separate a short course causing relapse from a
      milder illness being treated briefly.
  - reference: PMID:36029706
    reference_title: "Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we recommend that CLIPPERS be treated with high-dose steroid therapy for at least ten
      days during the acute phase with a very slow taper
    explanation: >-
      The recommendation the authors draw from that comparison.
- name: Intravenous Immunoglobulin
  description: >
    Tried for a relapse in one reported patient and did not work: no clinical improvement,
    while the same patient recovered promptly after each course of intravenous
    methylprednisolone. Recorded because a documented failure is what tells a clinician not
    to spend a relapse on it, and because the contrast with the steroid response in the same
    patient is the informative part. One patient, so this constrains the expected effect
    rather than excluding it.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: Intravenous Immunoglobulin Therapy
    term:
      id: NCIT:C121331
      label: Intravenous Immunoglobulin Therapy
    therapeutic_agent:
    - preferred_term: human immunoglobulin G
      term:
        id: NCIT:C80829
        label: Human Immunoglobulin G
  target_mechanisms:
  - target: Perivascular T-Lymphocytic Infiltration of Brainstem White Matter
    description: >-
      The intended target is the same infiltrate the corticosteroids suppress. The link is
      recorded with REFUTE evidence because the intervention was given and the infiltrate's
      clinical consequences did not remit.
    evidence:
    - reference: PMID:36938308
      reference_title: "Efficacy of Intravenous Immunoglobulins against Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids: A Case Report."
      supports: REFUTE
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Intravenous immunoglobulins (IVIg) were administered for recurrence, with no
        clinical improvement.
      explanation: >-
        The treatment reached the patient and the relapse did not respond, which is what
        makes this a refutation of the link rather than an absence of evidence about it.
  notes: >-
    therapeutic_modality is OTHER rather than PROTEIN_REPLACEMENT: pooled polyclonal IgG is
    given here as an immunomodulator in a patient with no immunoglobulin deficit, so the
    replacement reading would assert something the case does not support.
  evidence:
  - reference: PMID:36938308
    reference_title: "Efficacy of Intravenous Immunoglobulins against Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids: A Case Report."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      IVIg had a poor effect on the acute phase of CLIPPERS symptoms. Compared with other
      immunosuppressants, IVIg is less effective in suppressing the relapse of CLIPPERS.
    explanation: >-
      The authors' own conclusion, stated as a comparison against the immunosuppressants
      that do work, which is the clinically useful form of the finding.
discussions:
- discussion_id: clippers_infiltrate_lineage_contested
  kind: KNOWLEDGE_GAP
  prompt: >-
    Is the perivascular infiltrate in CLIPPERS T-cell dominant, as the founding and
    criteria-defining cohorts report, or can it be B-cell dominant?
  attaches_to:
  - pathophysiology#Perivascular T-Lymphocytic Infiltration of Brainstem White Matter
  rationale: >-
    The disease's histopathological signature, and the name of the node it occupies in this
    entry, is a perivascular CD3-positive T-lymphocytic infiltrate. A six-patient series from
    mainland China reports the opposite in most of its biopsies: of four patients with an
    infiltrate, one was CD3-dominant and three were CD20-dominant, and the authors state the
    generalisation rather than leaving it as a local observation.

    Both readings cannot be the disease's typical histology, and the difference is not
    cosmetic. A B-cell-dominant infiltrate would sit differently against the
    entity-versus-syndrome question recorded separately in this entry, since the lymphomas
    that have declared themselves in CLIPPERS patients have been B-cell lymphomas. It would
    also change which maintenance agent the mechanism argues for.

    This entry keeps the T-cell node because the larger and criteria-defining cohorts support
    it and because the downstream pathograph - barrier breakdown, tissue injury, brainstem
    dysfunction - is unaffected either way, but it does not present the lineage as settled.
    Resolving it needs a re-read of archived biopsies under one staining protocol rather
    than another case series.
  evidence:
  - reference: PMID:33498046
    reference_title: "Increased Number of Perivascular CD20-Positive B Lymphocytes in the Neuropathology of CLIPPERS: Findings of 6 Patients from Mainland China."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      among whom only 1 patient was dominated by CD3+ T cell infiltration and the other 3
      patients were dominated by CD20+ B cell infiltration
    explanation: >-
      Gives the split this discussion is about, with the denominator, in one sentence.
  - reference: PMID:20639547
    reference_title: "Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Neuropathology of biopsy material from four patients demonstrated white matter
      perivascular, predominantly T lymphocytic, infiltrate without granulomas, infection,
      lymphoma or vasculitis.
    explanation: >-
      The founding cohort's opposite finding, graded REFUTE against the B-cell-dominant
      claim rather than against the disease description, so that the disagreement is legible
      from either side.
  - reference: PMID:22777259
    reference_title: "Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among 7 available brain biopsy specimens, staining was positive for perivascular CD4 T
      lymphocytes in 5 samples.
    explanation: >-
      An independent nationwide series finding T-cell staining in most biopsies, which is
      why the T-cell reading is retained as the majority one.
- discussion_id: clippers_upstream_trigger_unknown
  kind: KNOWLEDGE_GAP
  prompt: >-
    What recruits the perivascular T-cell infiltrate in CLIPPERS, and against what antigen?
  attaches_to:
  - pathophysiology#Perivascular T-Lymphocytic Infiltration of Brainstem White Matter
  rationale: >-
    The pathograph in this entry begins at a tissue-level observation because nothing
    upstream of it has been established. No antigen, autoantibody, infectious trigger or
    susceptibility locus is known, and no diagnostic biomarker exists. The inference that
    the process is immune-mediated rests on two indirect arguments - the T-cell predominance
    of the infiltrate and the corticosteroid responsiveness - rather than on an identified
    immune target. Supplying a plausible upstream node here would misrepresent the state of
    the evidence, so the gap is recorded instead. It is also the gap that matters
    practically: a biomarker derived from the trigger is what would resolve the mimic
    problem recorded in the sibling discussion.
- discussion_id: clippers_entity_versus_syndrome
  kind: KNOWLEDGE_GAP
  prompt: >-
    Is CLIPPERS a single disease entity, or a syndrome that collects several overlapping
    diseases and the prodromal phases of some of them - CNS lymphoma in particular?
  attaches_to:
  - disease#Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive To Steroids
  rationale: >-
    This question was raised in print by the authors of the first fatal case and has not been
    settled. Patients meeting the full clinical, radiological and histopathological
    definition have gone on to biopsy-confirmed lymphomatoid granulomatosis and fatal CNS
    B-cell lymphoma, in one case after seven months of reliable steroid response. The 2017
    criteria sharpened the boundary but were derived from a cohort with a median follow-up
    of 44 months, and the concern is specifically about what declares itself later than
    that. The entity question bears directly on how this entry should be read: if CLIPPERS
    is partly a prodrome, then the pathograph above describes a common final inflammatory
    pattern rather than a disease mechanism.
  evidence:
  - reference: PMID:23649857
    reference_title: "Fatal B-cell lymphoma following chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Therefore, the question remains whether CLIPPERS is an actual new disease entity or
      represents a syndrome that includes different overlapping diseases and their
      prestages.
    explanation: >-
      States the open question in the authors' own words, which is what this discussion
      records rather than resolves.
  - reference: PMID:23649857
    reference_title: "Fatal B-cell lymphoma following chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      During follow-up, however, treatment failed, and he had a biopsy-confirmed diagnosis
      of lymphomatoid granulomatosis that evolved into fatal B-cell lymphoma of the central
      nervous system.
    explanation: >-
      Documents the specific course that motivates the question: a fully characterised
      CLIPPERS presentation that later proved to be an evolving lymphoma.
  - reference: PMID:36029706
    reference_title: "Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Sixteen percent of the cases were associated with malignancy, mostly hematologic
      malignancies.
    explanation: >-
      Moves the question from anecdote to a rate: one in six published cases carries a
      malignancy association, which is the scale of the problem the entity question is
      about.
  - reference: PMID:33658321
    reference_title: "Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      During follow-up, 3 of them displayed atypical findings for CLIPPERS, including
      emergence of systemic non-Hodgkin lymphoma (1/3) and confluent gadolinium-enhancing
      lesions on brain MRI (3/3).
    explanation: >-
      Shows the same divergence inside the genetic subgroup: three of four mutated patients
      stopped looking like CLIPPERS on follow-up, so the subgroup may be a separate disease
      rather than a genetic form of this one.
environmental:
- name: Intracranial Epstein-Barr virus infection
  description: >
    EBV has been reported within the CNS of a CLIPPERS patient, and EBV-driven B-cell
    lymphoma has emerged during paediatric CLIPPERS. Whether EBV is a trigger, a passenger
    reactivating under immunosuppression, or a marker of the lymphoproliferative process
    that some CLIPPERS turns out to be, is unresolved - the reported case had been in
    remission from Hodgkin lymphoma for eleven years before presenting. Recorded as
    MODULATES rather than TRIGGERS for that reason.
  influences_mechanisms:
  - target: Perivascular T-Lymphocytic Infiltration of Brainstem White Matter
    environmental_effect: MODULATES
    causal_link_type: UNKNOWN
    description: >-
      Association only. No study has shown that EBV initiates or sustains the infiltrate.
    evidence:
    - reference: PMID:27861371
      reference_title: "Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) with intracranial Epstein-Barr virus infection: A Case Report."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        we report a case of CLIPPERS presenting with intracranial Epstein-Barr virus (EBV)
        infection and diffuse white matter involvement
      explanation: >-
        Documents the co-occurrence of intracranial EBV with CLIPPERS. Graded INDIRECT
        because a single case of co-occurrence does not establish that the virus acts on the
        mechanism.
  evidence:
  - reference: PMID:27861371
    reference_title: "Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) with intracranial Epstein-Barr virus infection: A Case Report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The pathophysiology of CLIPPERS still remains unclear and the reports are quite few.
    explanation: >-
      Records the state of mechanistic knowledge against which this association has to be
      read: an unexplained disease, so an association is not yet a mechanism.

📚

References & Deep Research

References

10

PMID:20639547

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

No top-level findings curated for this source.

PMID:29050399

Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

No top-level findings curated for this source.

PMID:23649857

Fatal B-cell lymphoma following chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids.

No top-level findings curated for this source.

PMID:35126669

Brain biopsy in patients with CLIPPERS syndrome: why and when.

No top-level findings curated for this source.

PMID:23706003

Need for prolonged immunosupressive therapy in CLIPPERS--a case report.

No top-level findings curated for this source.

PMID:36029706

Clinical characteristics, management, and outcomes of CLIPPERS: A comprehensive systematic review of 140 patients from 100 studies.

No top-level findings curated for this source.

PMID:33658321

Hemophagocytic Lymphohistiocytosis Gene Mutations in Adult Patients Presenting With CLIPPERS-Like Syndrome.

No top-level findings curated for this source.

PMID:41781714

Two Cases of CLIPPERS-like Syndrome Sharing a Hypomorphic UNC13D Variant.

No top-level findings curated for this source.

PMID:28110629

CLIPPERS and the need for long-term immunosuppression.

No top-level findings curated for this source.

PMID:27861371

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) with intracranial Epstein-Barr virus infection: A Case Report.

No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Create: CLIPPERS · 2026-09-18T17:58:51Z · View source

De novo curation of CLIPPERS (MONDO:0017297) from an openscientist deep-research report plus independent PubMed reference work. Deep research: just research-disorder openscientist, report committed at research/Chronic_Lymphocytic_Inflammation_With_Pontine_Perivascular_Enhancement_Responsive_To_Steroids-deep-research-openscientist.md. Its frontmatter records reference_validation 25/25 verified, confabulation_rate 0.0, no unresolved references. Its term_validation reports labels_mismatched 7 with labels_matching 0; those are a parsing artifact, not wrong bindings - the report presents CURIEs in a table whose next column is a frequency word, and the validator read the frequency column (Common, Occasional, Frequent) as the term label. Each of the seven CURIEs is correct for what the report means. No binding in this entry was taken from that list without independent lookup. The entry was first built from the primary literature (Pittock 2010 PMID:20639547, Tobin 2017 diagnostic criteria PMID:29050399, the lymphoma-mimic reports PMID:23649857 and PMID:35126669), then substantially augmented from the report, which supplied content the first pass had missed: the Al-Chalabi systematic review of 140 patients (PMID:36029706) giving relapse rate 59.2 percent, overall mortality 10 percent and 30 percent with associated malignancy - which moved clinical_burden from MODERATE to HIGH - and the Taieb cohort (PMID:33658321) showing biallelic PRF1 or UNC13D mutations in 4 of 12 tested adult patients, replicated for UNC13D in PMID:41781714. That finding added a genetic section, a HYPOTHETICAL pathophysiology node for impaired cytotoxic granule-mediated killing, and an EMERGING mechanistic_hypotheses group that the corresponding causal edge opts into. Modelling decisions worth recording. The pathograph deliberately begins at a tissue-level observation (perivascular T-lymphocytic infiltration) because no upstream trigger is established; a KNOWLEDGE_GAP records that rather than supplying a plausible node. PRF1 and UNC13D are relationship_type SUSCEPTIBILITY, not CAUSATIVE, because it is unsettled whether those patients have CLIPPERS with a genetic modifier or a distinct HLH-spectrum disease presenting as CLIPPERS - three of the four mutated patients later showed atypical findings. EBV is environmental_effect MODULATES, not TRIGGERS, because the evidence is a single co-occurrence case. A second KNOWLEDGE_GAP records the unresolved entity-versus-syndrome question. Validation: just validate passes with 37/37 snippets verified against cached references; validate-terms, check-entity-refs, check-causal-targets, check-qualifier-terms, check-duplicate-keys and check-enum-values all pass. GeneReviews baseline: NO_CHAPTER for both Bookshelf collections, expected for a non-Mendelian syndrome named in 2010; recorded in the entry notes.

OpenScientist ▸

CLIPPERS: Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive To Steroids — Comprehensive Disease Report

openscientist-autonomous 24 citations 2026-09-18T17:49:23.976405

CLIPPERS: Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive To Steroids — Comprehensive Disease Report

MONDO ID: MONDO:0017297 | Category: Complex | Report date: 2026-09-18

Evidence base: aggregated disease-level literature (case reports, case series, retrospective cohorts, systematic reviews) — no primary patient-level dataset was provided. All quantitative statements come from the published literature cited by PMID.

Summary

Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS) is a rare, corticosteroid-responsive inflammatory syndrome of the central nervous system (CNS), first delineated in 2010. It is defined by the triad of (1) subacute pontocerebellar/brainstem clinical symptoms (most commonly gait ataxia, diplopia, dysarthria, and facial paresthesia), (2) a pathognomonic MRI signature of punctate and curvilinear gadolinium-enhancing lesions ("salt-and-pepper" or "pepper-like") predominantly peppering the pons and hindbrain, and (3) a perivascular, predominantly CD4+ T-lymphocytic inflammatory infiltrate on histopathology. The disease is exquisitely responsive to high-dose corticosteroids but follows a relapsing-remitting course that requires long-term steroid-sparing immunosuppression to prevent cumulative brainstem/cerebellar atrophy and permanent disability.

The single most important conceptual advance since the original description is that CLIPPERS is a syndrome, not a unitary disease — it is a diagnosis of exclusion that is genetically and etiologically heterogeneous. Most cases appear idiopathic/autoimmune, but approximately one-third of tested adults carry germline mutations in hemophagocytic lymphohistiocytosis (HLH) genes (notably PRF1 and UNC13D), defining a treatable genetic subgroup; approximately 16% of cases are associated with malignancy (chiefly hematologic); and some cases are triggered by or associated with Epstein–Barr virus (EBV). Several mimics — CNS lymphoma, Erdheim–Chester disease, GFAP astrocytopathy, MOGAD, neurosarcoidosis, and primary CNS angiitis — must be excluded, and some "CLIPPERS-like" presentations are early manifestations of lymphoma.

CLIPPERS is ultra-rare: the entire evidence base since 2010 comprises roughly 140 patients across 100 studies plus a handful of retrospective cohorts, with no population-based prevalence estimate, no validated animal model, and no primary or secondary prevention. Onset is typically adult (mean ~46 years; range 3–79) with a male predominance (~60%). Prognosis is favorable with sustained immunosuppression but poor if untreated — untreated relapses can progress to death. Pediatric CLIPPERS is more aggressive and often steroid-dependent or steroid-resistant. This report synthesizes 13 confirmed findings drawn from 37 reviewed papers across the full disease-characteristics template.

Key Findings

Finding 1 — Definition and pathognomonic imaging/pathology

CLIPPERS is a rare steroid-responsive CNS inflammatory syndrome centered on the pons and hindbrain, characterized by a distinctive "salt-and-pepper" gadolinium-enhancement pattern. In the 2017 formal diagnostic-criteria study (Tobin et al., Brain), CLIPPERS was diagnosed in 23 patients with a median age of onset of 58 years and a male predominance (18 male : 5 female). The hallmark MRI finding is punctate and curvilinear gadolinium-enhancing lesions ("pepper-like") predominantly in the pons, brainstem, and cerebellum, sometimes extending to the spinal cord. A definite diagnosis requires demonstration of a perivascular, T-cell-predominant inflammatory infiltrate on biopsy.

"CLIPPERS was diagnosed in 23 patients (18 male and five female) and 12 patients had a non-CLIPPERS diagnosis. CLIPPERS patients' median age of onset was 58 years" — PMID: 29050399

"The prerequisite for definite CLIPPERS is the perivascular T-cell-predominant inflammatory infiltration observed on pathological analysis." — PMID: 38286842

Finding 2 — Relapsing-remitting course requiring long-term immunosuppression

CLIPPERS follows a relapsing-remitting course; untreated disease progresses to disability and death. In the nationwide series of 12 patients (Taieb et al., 2012), 42 relapses were analyzed with a mean relapse duration of 2.5 months and a mean Expanded Disability Status Scale (EDSS) at relapse of 4, improving to a residual EDSS of 1.9 after pulse corticosteroids. Biopsy showed perivascular CD4+ T lymphocytes in 5/7 cases with an increased CD4:CD8 ratio. Critically, one patient with untreated relapses progressed to EDSS 10 (death), and patients not maintained on long-term corticosteroids had higher annualized relapse rates. Multiple 2025–2026 case reports confirm that relapses are typically tied to steroid taper and are controlled with steroid-sparing agents (methotrexate, mycophenolate mofetil).

"Thirty-eight of 42 relapses were treated with pulse corticosteroid therapy, which led to improvement, with a mean residual EDSS score of 1.9" — PMID: 22777259

"In 1 patient with untreated relapses, scores on the EDSS progressively increased to a score of 10 at death." — PMID: 22777259

Finding 3 — Paraneoplastic/pre-lymphomatous and genetic mimics

CLIPPERS can be a paraneoplastic or pre-lymphomatous mimic, and inborn errors of immunity underlie some (especially pediatric) cases. Multiple biopsy-confirmed cases show CLIPPERS-like presentations preceding or accompanying lymphoma (B-cell, cutaneous/peripheral T-cell lymphoma). Genetic associations include compound heterozygous UNC13D (Munc13-4) variants producing a CLIPPERS-like syndrome, and pediatric reviews flag PRF1 (perforin) mutations with links to HLH/EBV-driven lymphoproliferation, sometimes requiring hematopoietic stem cell transplant.

"We report two patients with CLIPPERS-like brain MRI findings who carried the same missense UNC13D variant in one allele along with deleterious variants in the opposite allele." — PMID: 41781714

"Future pediatric workup should include genetic studies because of commonly associated mutations such as PRF1." — PMID: 41401665

"CLIPPERS-like presentations have been increasingly recognized as potential early manifestations of underlying lymphoma, most commonly B-cell types." — PMID: 41550451

Finding 4 — Phenotype and epidemiology

In a systematic review of 140 patients from 100 studies (Al-Chalabi et al., 2022), the mean age was 46 ± 18 years, 60% were male, ataxia was the most common presenting symptom, 16% of cases were associated with malignancy (mostly hematologic), and the overall relapse rate was 59.2%. The core clinical tetrad from case series comprises gait ataxia, diplopia (internuclear ophthalmoplegia / cranial nerve VI palsy / skew deviation), cerebellar dysarthria, and facial paresthesia; nystagmus, dysphagia, and cognitive impairment also occur. The original 2010 description reported patients presenting with episodic diplopia or facial paresthesias followed by brainstem/myelopathic symptoms.

"We identified 100 case reports and series including a total of 140 patients with CLIPPERS (mean age: 46±18 years and males were 60%)... Ataxia was the most common presenting symptom. Sixteen percent of the cases were associated with malignancy, mostly hematologic malignancies. The overall relapse rate was 59.2%" — PMID: 36029706

"All eight patients (five female, three male) presented with episodic diplopia or facial paresthesias with subsequent brainstem and occasionally myelopathic symptoms and had a favourable initial response to high dose glucocorticosteroids." — PMID: 20639547

Finding 5 — Pathophysiology and mimics

CLIPPERS pathophysiology is an immune-mediated, predominantly CD4+ T-cell perivascular inflammation of the hindbrain, with a defined MRI signature and important neoplastic/histiocytic mimics. Pathology consistently shows a perivascular and parenchymal T-lymphocytic (predominantly CD4+) infiltrate with variable CD20+ B cells; some Chinese series notably reported CD20+ B-cell-dominant infiltrates in a subset. The etiology "remains unclear but is believed to involve immune-mediated mechanisms." The MRI signature (2010) is symmetric curvilinear gadolinium enhancement "peppering the pons" and extending to medulla, brachium pontis, cerebellum, midbrain, and occasionally spinal cord; lesions lack restricted diffusion, have little perilesional edema, and are typically ≤3 mm. Key mimics with distinct pathophysiology include Erdheim–Chester disease (clonal histiocytes with MAPK-ERK/BRAF activation), CNS lymphoma, GFAP astrocytopathy, MOGAD, neurosarcoidosis, and primary CNS angiitis.

"All patients had symmetric curvilinear gadolinium enhancement peppering the pons and extending variably into the medulla, brachium pontis, cerebellum, midbrain and occasionally spinal cord." — PMID: 20639547

"ECD is a histiocytic neoplasm characterized by multiorgan infiltration of clonal histiocytes carrying activating variants of the MAPK-ERK pathway. Neurologic involvement occurs in up to 40% of ECD with frequent brainstem lesions that can mimic acquired neuroinflammatory disorders, such as CLIPPERS." — PMID: 39047207

"The etiology of CLIPPERS remains unclear, but it is believed to involve immune-mediated mechanisms." — PMID: 40821365

Finding 6 — Treatment ladder

High-dose corticosteroids induce remission; long-term steroid-sparing immunosuppression prevents relapse; IVIg is ineffective; and pediatric disease is aggressive. Induction typically uses high-dose IV methylprednisolone (e.g., 1 g/day × 5 days), producing rapid clinical and radiological improvement. Maintenance uses long-term low-dose corticosteroid or corticosteroid plus an immunosuppressant; agents reported include methotrexate, mycophenolate mofetil, rituximab, cyclophosphamide, hydroxychloroquine, azathioprine, natalizumab, and infliximab. IVIg showed poor efficacy for both acute treatment and relapse prevention. Pediatric CLIPPERS is more aggressive, often steroid-dependent/resistant, with deaths and progression to EBV-driven B-cell lymphoma; genetic cases may require hematopoietic stem cell transplant.

"Long-term low-dose corticosteroid maintenance therapy or corticosteroids coupled with immunosuppressants are recommended to prevent" [relapse] — PMID: 38286842

"IVIg had a poor effect on the acute phase of CLIPPERS symptoms. Compared with other immunosuppressants, IVIg is less effective in suppressing the relapse of CLIPPERS." — PMID: 36938308

"CLIPPERS disease in children is aggressive, with poor response to immunotherapy." — PMID: 30146710

Finding 7 — Diagnosis of exclusion

CLIPPERS diagnosis rests on characteristic MRI plus supportive CSF findings (mild lymphocytic pleocytosis, elevated protein), with biopsy reserved for red flags. CSF typically shows mild lymphocytic pleocytosis and elevated protein, with inconstant oligoclonal bands (4/12 in the Taieb series) and an increased CD4:CD8 T-cell ratio. No specific serum/CSF biomarker exists. Diagnosis follows the 2017 criteria: subacute pontocerebellar symptoms + punctate/curvilinear "salt-and-pepper" hindbrain gadolinium enhancement (individual lesions ≤3 mm, T2 abnormality not exceeding enhancement, no mass effect/restricted diffusion) + exclusion of mimics. "Probable" is clinicoradiologic; "definite" adds perivascular T-cell biopsy confirmation. Biopsy is strongly advised when red flags are present. Emerging tools include CSF circulating tumor DNA (ctDNA) to unmask occult lymphoma.

"We evaluated clinical, radiological and pathological features of patients referred for suspected CLIPPERS and propose diagnostic criteria to discriminate CLIPPERS from non-CLIPPERS aetiologies." — PMID: 29050399

"Cerebrospinal fluid (CSF) analysis showed lymphocytic pleocytosis and elevated protein, while infectious and neoplastic causes were ruled out." — PMID: 41249905

Finding 8 — HLH-gene mutations define a treatable genetic subgroup

A substantial subset (~one-third) of adult CLIPPERS carries germline HLH-gene mutations. In Taieb et al. 2021, among a cohort of 36 CLIPPERS-2017 patients, 12 consented to genetic testing of 8 primary HLH genes; mutations were identified in 4/12 (three with biallelic variants). HLH-associated genes govern cytotoxic granule-mediated killing: PRF1 (perforin, HGNC:8664, OMIM 170280), UNC13D (Munc13-4, HGNC:23147, OMIM 608897), STX11, STXBP2, plus RAB27A, LYST, SH2D1A, and XIAP. An independent report described compound-heterozygous UNC13D variants with downregulated Munc13-4 protein producing CLIPPERS-like disease.

"In our patients presenting with adult-onset CLIPPERS, one-third have HLH gene mutations. This genetic treatable condition should be searched in patients with CLIPPERS, especially in those presenting with atypical findings." — PMID: 33658321

"identified to have compound heterozygous UNC13D variants along with downregulated Munc13-4 p[rotein]" — PMID: 41781714

Finding 9 — Anatomical distribution

CLIPPERS centers on the pons/hindbrain but extends to spinal cord and supratentorial regions. Primary sites: pons (UBERON:0000988), middle cerebellar peduncle/brachium pontis, cerebellum (UBERON:0002037), medulla (UBERON:0001896), and midbrain (UBERON:0001891). Frequent extension: cervical/thoracic spinal cord (UBERON:0002240) with nodular enhancement and myelopathy/spastic paraparesis; supratentorial white matter, thalamus, basal ganglia, internal capsule, and corpus callosum/splenium. The affected tissue is CNS nervous tissue with perivascular (angiocentric) small-vessel targeting; lesions are typically bilateral/symmetric. Onset is subacute, mostly in adults (median ~46–58 years, reported ages 3–79), with a chronic relapsing-remitting course. Asymmetric or unilateral lesions are atypical and constitute a red flag.

"MRI showed characteristic punctate hyper-intensities with enhancement in the brain stem, cerebellar peduncles, and optic chiasm and diffuse nodular enhancement throughout the cervical and thoracic spinal cord." — PMID: 29055484

"predominantly involving the pons and cerebellar hemispheres, with additional foci in the left internal capsule, splenium of the corpus callosum, and supratentorial subcortical white matter" — PMID: 41749027

Finding 10 — Prognosis

CLIPPERS prognosis is favorable with sustained treatment, but recurrent untreated attacks cause cumulative brainstem/cerebellar atrophy and permanent disability. As stated by Abkur et al. (2017), long-term immunosuppression appears mandatory to achieve sustained remission and prevent atrophy-related disability. In the Taieb series, pulse steroids reduced mean EDSS from 4 (relapse) to a residual 1.9; patients off long-term steroids had higher annualized relapse rates; one untreated patient reached EDSS 10 (death). Prognostic red flags for worse outcome or an alternative diagnosis include steroid resistance, atypical/large (>3 mm) lesions, mass effect, longitudinally extensive transverse myelitis, systemic symptoms, young/pediatric onset, and underlying malignancy or an HLH-gene mutation.

"Long-term immunosuppression appears to be mandatory in order to achieve sustained remission and prevent disability related to atrophy of the structures involved in repeated attacks." — PMID: 28110629

Finding 11 — Idiopathic etiology; EBV and occult lymphoma as triggers

CLIPPERS is idiopathic/immune-mediated with no established environmental or lifestyle risk factors; EBV and occult lymphoma are recognized triggers/associations. Etiology and pathogenesis are explicitly stated as unknown in multiple sources. No toxin, radiation, occupational, dietary, smoking, or alcohol risk factor has been established. Recognized associations/triggers include intracranial EBV infection accompanying CLIPPERS, EBV-driven B-cell lymphoma emerging during pediatric CLIPPERS, and occult hematologic/solid malignancy in ~16%. The main non-modifiable "risk factors" are the immune/genetic host state (adult age, male sex, HLH-gene carriage) rather than exogenous exposures.

"Its etiology and pathogenesis are unknown, that together with the polymorphic and sometimes confounding neurological manifestations, and radiological findings represent a real diagnostic and therapeutic challenge for clinicians." — PMID: 33851608

"we report a case of CLIPPERS presenting with intracranial Epstein-Barr virus (EBV) infection and diffuse white matter involvement." — PMID: 27861371

Finding 12 — Ultra-rare, sporadic; no animal model; no primary prevention

CLIPPERS is an ultra-rare, sporadic, adult-onset syndrome with no formal prevalence estimate, no animal models, and no primary prevention. It is described as "very rare" with "only a few sporadic cases reported," and the largest synthesis is a systematic review of just 140 patients from 100 studies since the 2010 first description. No population-based incidence/prevalence figure exists in Orphanet or registries. Knowledge is derived entirely from aggregated case reports, case series, and a few retrospective cohorts (not EHR/population datasets). No validated animal (mouse/rat/zebrafish) or in vitro model of CLIPPERS exists; the HLH-gene subgroup shares biology with established Prf1-/- and Unc13d (jinx) HLH mouse models, but these model HLH — not CLIPPERS specifically. No natural analogue disease has been reported in other species (OMIA has no CLIPPERS entry). No primary or secondary prevention or vaccination applies; "prevention" is limited to tertiary prevention (maintenance immunosuppression to prevent relapse-related atrophy) and genetic counseling for the autosomal-recessive HLH-gene subgroup.

"A very rare inflammatory disease of CNS, CLIPPERS syndrome, was recently described and only a few sporadic cases are reported in the medical literature." — PMID: 33851608

"We identified 100 case reports and series including a total of 140 patients with CLIPPERS" — PMID: 36029706

Finding 13 — Consolidated synthesis

Integrating all findings: CLIPPERS is a steroid-responsive CD4+ T-cell perivascular hindbrain inflammatory syndrome, heterogeneous in cause, requiring lifelong immunosuppression. Its four pillars are (1) definition/imaging; (2) relapsing course with maintenance need; (3) etiologic heterogeneity — idiopathic autoimmune majority, autosomal-recessive HLH-gene subgroup in ~1/3 of tested adults (PRF1/UNC13D), paraneoplastic (~16% malignancy), and EBV-associated; (4) diagnosis of exclusion via 2017 criteria with CSF lymphocytic pleocytosis and no specific biomarker; treated by a ladder of high-dose corticosteroids → steroid-sparing agents (methotrexate, MMF, rituximab, natalizumab), with IVIg ineffective and HSCT for genetic/aggressive cases; and it is ultra-rare (~140 total reported cases) with no animal model and only tertiary prevention.

Section-by-Section Report

1. Disease Information

Overview. CLIPPERS is a rare CNS inflammatory syndrome, first named in 2010 (Pittock et al.), defined by subacute brainstem/cerebellar dysfunction, a distinctive "salt-and-pepper" pontine gadolinium enhancement pattern, and a perivascular T-cell inflammatory infiltrate that responds dramatically to corticosteroids.

Key identifiers. MONDO:0017297. It lacks a distinct OMIM number (it is not a single-gene Mendelian disorder). No dedicated ICD-10 code exists; it is generally coded under CNS inflammatory/demyelinating disease categories. It is recognized in the neuroimmunology literature and included in registries such as the Indian IMSRN cohort (PMID: 42011245, where CLIPPERS represented only 0.06% — 3 of 4,976 — of CNS demyelinating/allied disorders).

Synonyms. "CLIPPERS syndrome"; "CLIPPERS-like syndrome" (for cases pending exclusion of mimics). A supratentorial variant, SLIPPERS (Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids), is described but its independent existence is debated (PMID: 34345468, PMID: 37626547, PMID: 41718297).

Source of information. Disease-level, derived from aggregated case reports, case series, and small retrospective cohorts — not large EHR/population datasets (Findings 1, 12).

2. Etiology

Primary causes. Idiopathic/immune-mediated in the majority (Findings 5, 11). A treatable genetic subgroup carries biallelic HLH-gene mutations (~1/3 of tested adults; Finding 8). A paraneoplastic subgroup (~16%) is associated with malignancy, mostly hematologic (Finding 4). An infectious/EBV-associated subgroup exists (Finding 11).

Genetic risk factors. PRF1 (perforin), UNC13D (Munc13-4), and other primary HLH genes (STX11, STXBP2, RAB27A, LYST, SH2D1A, XIAP) — cytotoxic-granule pathway genes (Finding 8).

Environmental risk factors. None established. Non-modifiable host factors: adult age, male sex, HLH-gene carriage (Finding 11).

Protective factors. None described (not reported / not applicable).

Gene–environment interactions. Plausibly, HLH-gene hypomorphism impairs cytotoxic clearance of EBV-infected/antigen-presenting cells, permitting EBV-driven or antigen-driven T-cell perivascular inflammation — an inferred mechanism, not demonstrated (Findings 3, 8, 11).

3. Phenotypes

Phenotype	Type	Frequency / notes	Suggested HPO
Gait ataxia	Clinical sign	Most common presenting symptom	HP:0002066 / HP:0001251
Diplopia (INO, CN VI palsy, skew)	Symptom/sign	Common; sometimes predominant	HP:0000651
Dysarthria (cerebellar)	Clinical sign	Common	HP:0001260
Facial paresthesia	Symptom	Common; early	HP:0003401
Nystagmus	Clinical sign	Frequent	HP:0000639
Dysphagia	Symptom	Occasional	HP:0002015
Cognitive impairment	Symptom	Occasional	HP:0100543
Spastic paraparesis/myelopathy	Sign	With spinal cord involvement	HP:0001258

Characteristics. Onset subacute, adult-predominant (mean ~46 yrs, range 3–79); severity variable; progression episodic/relapsing-remitting and progressive if untreated; relapse rate ~59% (Findings 4, 9). CSF: mild lymphocytic pleocytosis, elevated protein, increased CD4:CD8 ratio (Finding 7). Quality of life: driven by disability from brainstem/cerebellar dysfunction; EDSS improves from ~4 (relapse) to residual ~1.9 with treatment (Findings 2, 10).

4. Genetic/Molecular Information

Causal genes (subgroup). PRF1 (HGNC:8664, OMIM 170280), UNC13D (HGNC:23147, OMIM 608897); additional HLH genes as above (Finding 8).

Pathogenic variants. Compound heterozygous/biallelic missense and deleterious variants; e.g., a hypomorphic UNC13D missense variant with a deleterious variant in trans, and downregulated Munc13-4 protein (Findings 3, 8). Variant classification per ACMG/AMP: pathogenic/likely pathogenic in described families; functional consequence is loss of function (impaired cytotoxic degranulation). Somatic vs germline: germline. Population allele frequencies for individual HLH variants are typically rare (gnomAD); specific per-variant frequencies were not enumerated in the CLIPPERS literature reviewed.

Modifier genes / epigenetics / chromosomal abnormalities. Not established for CLIPPERS (not reported).

5. Environmental Information

No environmental, occupational, or lifestyle factors are established (Finding 11). Infectious agents: EBV is a recognized association/trigger (intracranial EBV infection with CLIPPERS; EBV-driven B-cell lymphoma in pediatric CLIPPERS) — PMID: 27861371, PMID: 30146710. CHEBI-relevant therapeutic entities include prednisolone/methylprednisolone (CHEBI:8378 / CHEBI:6888).

6. Mechanism / Pathophysiology

Ordered causal chain (initiating lesion → clinical manifestation):

1. Predisposing host state — germline HLH-gene hypomorphism (PRF1/UNC13D loss of
   function) OR occult neoplasm OR EBV infection OR unknown idiopathic trigger
│  leads to
▼
2. Impaired cytotoxic-lymphocyte granule-mediated killing (inferred, for the
   HLH-gene subgroup) OR sustained antigenic stimulation
│  results in
▼
3. Failure to clear activated antigen-presenting cells / infected cells →
   persistent T-cell activation (inferred)
│  leads to
▼
4. Angiocentric homing of predominantly CD4+ T lymphocytes (± CD20+ B cells) to
   small vessels of the pons/hindbrain (demonstrated on biopsy)
│  results in
▼
5. Perivascular ("perivascular-cuffing") lymphocytic inflammation with
   blood–brain-barrier disruption → punctate/curvilinear gadolinium enhancement
   ("salt-and-pepper") (demonstrated: MRI + histology)
│  leads to
▼
6. Local tissue dysfunction of pontocerebellar tracts and cranial-nerve nuclei →
   ataxia, diplopia, dysarthria, facial paresthesia (demonstrated clinically)
│  branch (untreated / recurrent attacks)
▼
7. Cumulative brainstem/cerebellar atrophy → permanent disability, death
   (demonstrated: EDSS progression to 10 in an untreated patient)
│  branch (some cases)
▼
7'. Evolution to / unmasking of CNS or systemic lymphoma (demonstrated in
    paraneoplastic subgroup)

Molecular/cellular detail. Immune-mediated perivascular inflammation (GO:0006954 inflammatory response; GO:0002250 adaptive immune response). Cell types: CD4+ T lymphocyte (CL:0000624), CD8+ T lymphocyte (CL:0000625), B lymphocyte (CL:0000236). For the HLH-gene subgroup, the defective process is cytotoxic-granule exocytosis/regulated secretory pathway (GO:0045055; perforin/Munc13-4 function). The MAPK-ERK pathway is relevant only to the Erdheim–Chester mimic, not CLIPPERS itself (Finding 5). Upstream = host predisposition (genetic/neoplastic/infectious); downstream = perivascular T-cell inflammation and tissue injury.

7. Anatomical Structures Affected

Primary: pons (UBERON:0000988), middle cerebellar peduncle/brachium pontis, cerebellum (UBERON:0002037), medulla (UBERON:0001896), midbrain (UBERON:0001891).
Secondary/extension: cervical & thoracic spinal cord (UBERON:0002240), supratentorial white matter, thalamus, basal ganglia, internal capsule, corpus callosum/splenium, optic chiasm.
Body system: central nervous system (nervous system).
Tissue/cell: CNS nervous tissue; perivascular (angiocentric) small vessels; CD4+ T lymphocytes (CL:0000624), variable CD20+ B cells (CL:0000236).
Lateralization: typically bilateral/symmetric; unilateral/asymmetric is a red flag (Finding 9).

8. Temporal Development

Onset subacute, adult-predominant (median ~46–58 yrs; reported 3–79). Course: chronic relapsing-remitting; mean relapse duration ~2.5 months; ~59% relapse rate; progressive and potentially fatal if untreated. Remission is treatment-induced (steroid pulse); relapses cluster around steroid taper/discontinuation. Critical intervention window: early corticosteroid initiation and sustained maintenance to prevent irreversible atrophy (Findings 2, 4, 9, 10).

9. Inheritance and Population

Epidemiology. Ultra-rare; no formal prevalence/incidence figure exists (~140 total reported patients). Male predominance (~60%). Inheritance (genetic subgroup): autosomal recessive (biallelic HLH-gene variants); the idiopathic majority is sporadic/non-Mendelian. Penetrance, expressivity, anticipation, mosaicism, founder effects, consanguinity, and carrier frequencies specific to CLIPPERS are not characterized. Demographics: no defined ethnic/geographic predisposition; cases reported worldwide (Findings 8, 12).

10. Diagnostics

Imaging (key): MRI with gadolinium — punctate/curvilinear "salt-and-pepper" enhancement in pons/hindbrain; lesions ≤3 mm, no restricted diffusion, minimal edema, no mass effect.
CSF: mild lymphocytic pleocytosis, elevated protein, increased CD4:CD8 ratio, inconstant oligoclonal bands; no specific biomarker.
Biopsy: perivascular T-cell (CD4+ predominant) infiltrate; required for definite diagnosis and when red flags present.
Genetic testing: panel of primary HLH genes (PRF1, UNC13D, STX11, STXBP2, RAB27A, LYST, SH2D1A, XIAP) recommended, especially with atypical features (Finding 8).
Emerging: CSF ctDNA to detect occult lymphoma (Finding 7).
Criteria: 2017 Tobin/Mayo criteria — "probable" (clinicoradiologic) vs "definite" (plus biopsy).
Differential diagnosis: CNS lymphoma (PCNSL), Erdheim–Chester disease, GFAP astrocytopathy, MOGAD, NMOSD, neurosarcoidosis, primary CNS angiitis, Behçet, Susac syndrome (Findings 5, 7).

11. Outcome/Prognosis

Favorable with sustained immunosuppression (residual EDSS ~1.9); poor if untreated (progression to EDSS 10/death). Chief complication is cumulative brainstem/cerebellar atrophy from repeated attacks. Worse-prognosis red flags: steroid resistance, large/atypical lesions, mass effect, longitudinally extensive transverse myelitis, systemic symptoms, pediatric onset, malignancy, HLH-gene mutation (Finding 10).

12. Treatment

Line	Intervention	Notes	Suggested NCIT
Induction	High-dose IV methylprednisolone (e.g., 1 g/day × 5 d)	Rapid clinical/radiologic response	C29383 (Corticosteroid)
Maintenance	Low-dose corticosteroid ± steroid-sparing agent	Prevents relapse-related atrophy	C29383
Steroid-sparing	Methotrexate, mycophenolate mofetil	Sustains remission	C642 (Methotrexate); C61501 (MMF)
Steroid-sparing (alt.)	Rituximab, cyclophosphamide, azathioprine, hydroxychloroquine, natalizumab, infliximab	Case-based use	C1702 (Rituximab); C405 (Cyclophosphamide)
Not recommended	IVIg	Poor efficacy acutely and for relapse prevention	C513 (IVIG)
Genetic/aggressive	Hematopoietic stem cell transplant	For HLH-gene/pediatric refractory cases	C15431 (HSCT)

Pharmacogenomics/personalized medicine: genotype-guided care applies to the HLH-gene subgroup (consider HSCT and HLH-directed management). (Finding 6.)

13. Prevention

No primary or secondary prevention or vaccination applies. Tertiary prevention = maintenance immunosuppression to prevent relapse-related atrophy and disability. Genetic counseling is relevant for the autosomal-recessive HLH-gene subgroup. Surveillance for occult malignancy is prudent given ~16% association (Findings 6, 10, 12).

14. Other Species / Natural Disease

No naturally occurring CLIPPERS analogue is reported in other species (OMIA has no entry; Finding 12). Orthologous HLH-pathway genes exist across mammals (Prf1, Unc13d in mouse; NCBI Taxon 10090). No zoonotic or cross-species transmission (not applicable — CLIPPERS is non-infectious/immune-mediated).

15. Model Organisms

No validated animal or in vitro model of CLIPPERS exists. The HLH-gene subgroup shares biology with established HLH mouse models — Prf1-/- (perforin knockout) and Unc13d (jinx) mice — but these recapitulate HLH, not CLIPPERS's pontine perivascular phenotype (Finding 12). Model resources for the underlying genes: MGI (mouse), plus IMPC/KOMP knockout lines for Prf1/Unc13d. A key limitation is that no model reproduces the hallmark salt-and-pepper hindbrain enhancement.

Mechanistic Model / Interpretation

CLIPPERS is best understood as a radiologic-histologic reaction pattern (perivascular, CD4+ T-cell-predominant hindbrain inflammation producing salt-and-pepper enhancement) that can arise from multiple upstream causes rather than a single etiologic disease. The unifying downstream event is angiocentric lymphocytic inflammation of pontine/cerebellar small vessels with blood–brain-barrier breakdown; the divergent upstream drivers are (a) idiopathic autoimmunity, (b) biallelic HLH-gene loss of function impairing cytotoxic clearance, (c) paraneoplasia/occult lymphoma, and (d) EBV.

┌─────────────── UPSTREAM DRIVERS (heterogeneous) ───────────────┐
│  Idiopathic     HLH-gene LOF      Occult neoplasm     EBV       │
│  autoimmune    (PRF1/UNC13D)      (~16%)           infection    │
└───────┬───────────────┬───────────────┬───────────────┬────────┘
└───────────────┴───────┬───────┴───────────────┘
                        ▼
      CONVERGENT LESION: perivascular CD4+ T-cell inflammation
        of pons/hindbrain small vessels
                        ▼
      MRI SIGNATURE: punctate/curvilinear "salt-and-pepper"
         gadolinium enhancement (≤3 mm)
                        ▼
      CLINICAL: ataxia, diplopia, dysarthria, facial paresthesia
                        ▼
┌───────────────── OUTCOME (treatment-dependent) ────────────────┐
│  Treated → remission (EDSS ~1.9)  │  Untreated → atrophy, death │
└────────────────────────────────────────────────────────────────┘

This model explains why CLIPPERS is a diagnosis of exclusion, why genetic testing and malignancy surveillance are essential, and why the same corticosteroid-responsive phenotype can carry radically different prognoses depending on the upstream driver.

Evidence Base

PMID	Contribution	Supports finding(s)
29050399	2017 diagnostic criteria; cohort of 23 CLIPPERS vs 12 non-CLIPPERS; age/sex	F1, F7, F13
22777259	12-patient series; 42 relapses; EDSS outcomes; death untreated; CD4 biopsy	F2, F10
36029706	Systematic review 140 patients; epidemiology, 16% malignancy, 59.2% relapse	F4, F11, F12, F13
20639547	Original 2010 description; MRI signature; presenting symptoms	F1, F4, F5
33658321	HLH-gene mutations in ~1/3 of adult CLIPPERS	F8, F13
41781714	Compound-het UNC13D with downregulated Munc13-4 in CLIPPERS-like disease	F3, F8
41401665	Pediatric CLIPPERS; PRF1; genetic workup recommended	F3, F6
41550451	CLIPPERS-like as early lymphoma manifestation; CSF ctDNA	F3, F7
38286842	Contemporary review; pathology prerequisite; maintenance therapy; no biomarker	F1, F6, F7
39047207	Erdheim–Chester (MAPK-ERK) mimic of CLIPPERS	F5
40821365	Immune-mediated etiology; advanced MRI	F5
36938308	IVIg ineffective	F6
30146710	Aggressive pediatric disease; EBV-driven lymphoma	F6, F11
41249905	Typical CSF profile; exclusionary diagnosis	F7
29055484	Spinal cord + optic chiasm involvement	F9
41749027	Pontocerebellar predominance with supratentorial extension	F9
28110629	Atrophy from repeated attacks; mandatory long-term immunosuppression	F10
33851608	Idiopathic; very rare/sporadic	F11, F12
27861371	Intracranial EBV association	F11
41756550	Corpus callosum involvement; MMF maintenance; relapse on taper	F2, F9
33498046	CD20+ B-cell-dominant infiltrate in a subset (challenges CD4+ canon)	F5

Supporting registry context: PMID: 42011245 (IMSRN) records CLIPPERS at only 0.06% of CNS demyelinating/allied disorders, corroborating extreme rarity.

Limitations and Knowledge Gaps

Evidence quality is low. The entire literature is case reports, small series, and a single systematic review (~140 patients). No randomized trials, no population registries, and no formal prevalence estimate exist.
No specific biomarker. Diagnosis remains exclusionary; the boundary between CLIPPERS and mimics (PCNSL, ECD, GFAP astrocytopathy, MOGAD, PACNS) is imperfect, and some "CLIPPERS" cases are misclassified lymphoma or vasculitis.
Mechanism largely inferred. The link from HLH-gene loss of function → impaired cytotoxicity → perivascular T-cell inflammation is biologically plausible but not experimentally demonstrated in CLIPPERS tissue.
Genetic penetrance/frequency unknown. How often HLH-gene carriers develop CLIPPERS, and the population frequency of the relevant variants in CLIPPERS patients, are not quantified.
B-cell vs T-cell heterogeneity. Some series report CD20+ B-cell-dominant infiltrates (PMID: 33498046), challenging the "CD4+ T-cell" canonical model.
No animal model reproduces the pontine salt-and-pepper phenotype, limiting mechanistic and therapeutic research.
Pediatric vs adult disease may be biologically distinct entities (PMID: 30146710).

Proposed Follow-up Experiments / Actions

Systematic HLH-gene sequencing in all new CLIPPERS cases (adult and pediatric) with functional degranulation assays (perforin expression, CD107a mobilization) to quantify the genetic subgroup and confirm loss of function.
Prospective CSF ctDNA and T-cell-receptor clonality studies at diagnosis and relapse to systematically detect occult lymphoma and refine the paraneoplastic fraction.
International CLIPPERS registry with standardized 2017-criteria phenotyping, MRI, biopsy, genetics, and longitudinal EDSS to generate the first prevalence/incidence estimates and natural-history data.
Comparative immunohistochemistry meta-analysis to resolve the CD4+ T-cell vs CD20+ B-cell heterogeneity and its clinical/prognostic correlates.
Head-to-head observational comparison of steroid-sparing agents (methotrexate vs MMF vs rituximab) for relapse prevention and atrophy protection.
Develop a conditional/hypomorphic HLH-gene mouse challenged with an EBV-analogue (MHV-68) or antigenic stimulation to test whether cytotoxic-clearance failure can generate perivascular hindbrain inflammation.
Standardized malignancy-surveillance protocol (whole-body PET/CT, hematologic workup) for CLIPPERS patients given the ~16% malignancy association.

Report compiled from 13 confirmed findings and 37 reviewed papers over 5 investigation iterations. Ontology suggestions: MONDO:0017297; HPO terms per Section 3; GO:0006954, GO:0002250, GO:0045055; CL:0000624, CL:0000625, CL:0000236; UBERON:0000988, 0002037, 0001896, 0001891, 0002240; NCIT terms per Section 12.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	25
Resolved	25
Unresolved (possible confabulation)	0
Unverifiable	0
References weighed for topical relevance	25
On topic	18
Off topic	0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome	Count
Terms checked	25
Resolved	23
Unresolved (possible confabulation)	0
Obsolete	0
Unverifiable	2
Terms whose name was checked	8
Terms named correctly	0
Terms named as a different term	7
Terms whose name is worth a second look	1

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

UBERON:0002240 (2 mentions) - the report calls it "Secondary/extension: cervical & thoracic spinal cord"; UBERON calls it spinal cord**
HP:0000651 (1 mention) - the report calls it "Common; sometimes predominant"; HP calls it Diplopia
HP:0001260 (1 mention) - the report calls it "Common"; HP calls it Dysarthria
HP:0003401 (1 mention) - the report calls it "Common; early"; HP calls it Paresthesia
HP:0000639 (1 mention) - the report calls it "Frequent"; HP calls it Nystagmus
HP:0002015 (1 mention) - the report calls it "Occasional"; HP calls it Dysphagia
HP:0100543 (1 mention) - the report calls it "Occasional"; HP calls it Cognitive impairment

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

UBERON:0000988 (3 mentions) - the report calls it "Primary: pons"; UBERON calls it pons**

Ask OpenScientist

OpenScientist Report

Mechanistic Hypotheses

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Environmental Factors

Diagnosis

Progression

Prevalence

Clinical Burden

Source YAML

References & Deep Research

References

Deep Research

CLIPPERS: Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive To Steroids — Comprehensive Disease Report

Summary

Key Findings

Finding 1 — Definition and pathognomonic imaging/pathology

Finding 2 — Relapsing-remitting course requiring long-term immunosuppression

Finding 3 — Paraneoplastic/pre-lymphomatous and genetic mimics

Finding 4 — Phenotype and epidemiology

Finding 5 — Pathophysiology and mimics

Finding 6 — Treatment ladder

Finding 7 — Diagnosis of exclusion

Finding 8 — HLH-gene mutations define a treatable genetic subgroup

Finding 9 — Anatomical distribution

Finding 10 — Prognosis

Finding 11 — Idiopathic etiology; EBV and occult lymphoma as triggers

Finding 12 — Ultra-rare, sporadic; no animal model; no primary prevention

Finding 13 — Consolidated synthesis

Section-by-Section Report

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic/Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome/Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Mechanistic Model / Interpretation

Evidence Base

Limitations and Knowledge Gaps

Proposed Follow-up Experiments / Actions

Artifacts

Reference Validation

Term Validation

Terms the report names something else

Terms whose name is worth a second look